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Abstract
The aim of genetic epidemiology is to understand the effects of genes and environ-
mental factors on human health. In recent years there have been many studies of
association with the goal of studying the role of the genetic component in the risk for
common diseases such as diabetes, cardiovascular disease, cancer, Alzheimer’s, etc.
These studies are usually based on a selection of genetic markers which are geno-
typed for samples of diseased (cases) and healthy (controls) individuals in order to
study the level of association with disease.
This thesis is focused on ”Genomic Profiling” which refers to the identification of
genetic variants at multiple loci for prediction of disease risk. This involves variable
selection and model building. A common strategy for genomic profiling consists in
building a disease prediction model that only contains those genetic markers with a
marginal significant effect on the disease. This marginal approach has an important
limitation, it ignores epistasis. From a statistical point of view, an epistatic effect or
a genetic interaction is present when the combined effect of several genetic markers
on the observed phenotype is not explained by their marginal effects. The main
difficulty in the study of genetic interactions is that usually hundreds or thousands
of genetic markers are analyzed, which makes the analysis of all possible interactions
unfeasible, from a computational point of view. As a consequence of this, most
available methods for epistasis analysis only allow the study of low order interactions,
ix
xsecond or third order interactions.
In this thesis we present two new methodological approaches to address genomic
profiling in presence of epistasis which allow higher order interactions to be explored
with a reasonable computational cost.
The first method, called AUC-RF, is based on a classification methodology widely
used in the context of automated learning techniques called Random Forest (RF).
The AUC-RF algorithm implements a backward variable selection based on opti-
mizing the ROC curves of the RF. This process provides the set of genetic markers
with the highest predictive value of the disease risk.
The RF provides a ranking of the predictor variables based on some measures of
importance implemented in the method. The two most commonly used impor-
tance measures are the mean decrease accuracy (MDA) and the mean decrease Gini
(MDG). In this thesis we present a study in which we explored the stability and
robustness of these two measures of importance. The results of this study show that
MDA is very unstable and MDG provides more appropriate rankings for the pre-
dictor variables that are actually associated with the response variable. This result
justifies the use of the MDG importance measure in the AUC-RF methodology.
The second proposed method, called Optimal AUC, is based on the concept of
optimal ROC curves. The objective is again obtaining sets of genetic variables with
the highest predictive capability, now through the optimum combination of variables
based on likelihood ratio measures. In this case the proposed algorithm performs a
forward selection of variables that can identify genetic interactions of higher order,
i.e. a large number of variables, and is computationally feasible.
Another prominent issue addressed in this thesis is the simulation of data with simi-
lar properties to real genetic association studies. Simulation studies are very impor-
tant in the development and evaluation of new methods. Power and effectiveness
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can be gauged using datasets from which known results are obtained. Comparison of
results obtained using different techniques is possible as well as an evaluation of the
effectiveness of the methodology by varying simulation parameters. With this pur-
pose we developed a set of R functions to simulate genotyping data and associated
response variable based on risk models.
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Resumen
El objetivo de la epidemiolog´ıa gene´tica es comprender los efectos de los genes y
los factores ambientales en la salud humana. En los u´ltimos an˜os se han realizado
muchos estudios de asociacio´n con el propo´sito de estudiar el papel del componente
gene´tico en el riesgo de enfermedades comunes como la diabetes, enfermedades car-
diovasculares, ca´ncer, Alzheimer, etc. Estos estudios se basan por lo general en una
seleccio´n de marcadores gene´ticos que se genotipan para muestras de individuos en-
fermos (casos) y sanos (controles) con el fin de estudiar el nivel de asociacio´n con la
enfermedad.
Esta tesis se centra en lo que se denomina ”Genomic Profiling”, que se refiere a
la identificacio´n de mu´ltiples variantes gene´ticas para predecir el riesgo a la enfer-
medad. Esto implica una seleccio´n de variables y la construccio´n de un modelo.
Una estrategia comu´n consiste en la construccio´n de un modelo de prediccio´n que
contenga u´nicamente los marcadores gene´ticos con un efecto marginal significativo
sobre la enfermedad. Este enfoque marginal tiene una limitacio´n importante, ignora
la epistasis. Desde un punto de vista estad´ıstico, un efecto epista´tico o una interac-
cio´n gene´tica aparece cuando el efecto conjunto de varios marcadores gene´ticos sobre
el fenotipo observado no queda explicado por sus efectos marginales. La principal
dificultad en el estudio de las interacciones gene´ticas es que generalmente se analizan
cientos o miles de marcadores gene´ticos, lo que hace inviable el ana´lisis de todas las
xiii
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posibles interacciones, desde el punto de vista computacional. Como consecuencia
de ello, la mayor´ıa de los me´todos disponibles para el ana´lisis de epistasis so´lo per-
miten el estudio de las interacciones de orden inferior, interacciones de segundo o
tercer orden.
En esta tesis presentamos dos aproximaciones metodolo´gicas nuevas para la identi-
ficacio´n de perfiles gene´ticos en presencia de epistasis que permiten explorar inte-
racciones de alto orden con un coste computacional razonable.
La primera de las metodolog´ıas presentadas, denominada AUC-RF, se basa en un
me´todo de clasificacio´n ampliamente utilizado en el contexto de las te´cnicas de
aprendizaje automatizado denominado Random Forest (RF). El algoritmo AUC-RF
implementa una seleccio´n de variables hacia atra´s basada en la optimizacio´n de las
curvas ROC del RF que permite identificar conjuntos de marcadores gene´ticos con
el mayor valor predictivo sobre el riesgo a la enfermedad.
Un RF proporciona una ordenacio´n de las variables predictoras en base a algunas
de las medidas de importancia que el me´todo tiene implementado. Las dos medi-
das ma´s utilizadas son el mean decrease accuracy (MDA) y el mean decrease Gini
(MDG). En esta tesis presentamos un trabajo en el que hemos explorado la esta-
bilidad y la robustez de estas dos medidas de importancia. Los resultados de este
estudio ponen de manifiesto que MDA es muy inestable y que MDG proporciona
unos rankings ma´s adecuados para las variables predictoras que realmente esta´n
asociadas con la variable respuesta. Este resultado justifica que en la metodolog´ıa
AUC-RF utilizamos la medida de importancia MDG.
La segunda metodolog´ıa propuesta, denominada Optimal AUC, se basa en el con-
cepto de curvas ROC o´ptimas. El objetivo vuelve a ser la obtencio´n de conjuntos
de variables gene´ticas con la ma´xima capacidad predictiva, en este caso basa´ndonos
en la combinacio´n o´ptima de variables en base a medidas de razo´n de verosimilitud.
En este caso el algoritmo que proponemos realiza una seleccio´n de variables hacia
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adelante que permite identificar interacciones gene´ticas de alto orden, es decir, con
un nu´mero elevado de variables, y abordable desde el punto de vista computacional.
Otro aspecto importante que abordamos en esta tesis es la simulacio´n de datos que
cumplan ciertas propiedades similares a datos reales. Los estudios de simulacio´n
tienen mucha importancia en el desarrollo y evaluacio´n de nuevas metodolog´ıas
porque permiten analizar su potencia y efectividad en conjuntos de datos para los
que se conoce cua´l deber´ıa ser el resultado correcto a obtener, permiten comparar
los resultados obtenidos con otras te´cnicas y permiten analizar co´mo se ve afectada
la efectividad de la metodolog´ıa al variar los para´metros de simulacio´n. Con este
propo´sito, hemos desarrollado un conjunto de funciones de R para simular los datos
de genotipos y la variable respuesta asociada en base a modelos de riesgo.
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Resum
L’objectiu de l’epidemiologia gene`tica e´s comprendre els efectes dels gens i els factors
ambientals en la salut humana. En els u´ltims anys s’han realitzat molts estudis
d’associacio´ amb el propo`sit d’estudiar el paper de la component gene`tica en el risc
de malalties comunes com la diabetis, malalties cardiovasculars, ca`ncer, Alzheimer,
etc. Aquests estudis es basen en general en una seleccio´ de marcadors gene`tics que es
genotipen per a mostres d’individus malalts (casos) i sans (controls) amb la finalitat
d’estudiar el nivell d’associacio´ amb la malaltia.
Aquesta tesi es centra en el que es denomina ”Genomic Profiling”, que es refereix
a la identificacio´ de mu´ltiples variants gene`tiques per predir el risc a la malaltia.
Aixo` implica una seleccio´ de variables i la construccio´ d’un model. Una estrate`gia
comuna consisteix en la construccio´ d’un model de prediccio´ que contingui u´nicament
els marcadors gene`tics amb un efecte marginal significatiu sobre la malaltia. Aquest
enfocament marginal te´ una limitacio´ important, ignora l’epistasi. Des d’un punt de
vista estad´ıstic, un efecte epista`tic o una interaccio´ gene`tica apareix quan l’efecte
conjunt de diversos marcadors gene`tics sobre el fenotip observat no queda explicat
pels seus efectes marginals. La principal dificultat en l’estudi de les interaccions
gene`tiques e´s que generalment s’analitzen centenars o milers de marcadors gene`tics,
i aixo` fa inviable l’ana`lisi de totes les possibles interaccions, des del punt de vista
computacional. Com a consequ¨e`ncia d’aixo`, la majoria dels me`todes disponibles
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per a l’ana`lisi d’epistasi nome´s permeten l’estudi de les interaccions d’ordre inferior,
interaccions de segon o tercer ordre.
En aquesta tesi presentem dues aproximacions metodolo`giques per a la identificacio´
de perfils gene`tics en prese`ncia d’epistasi que permeten explorar interaccions d’ordre
alt amb un cost computacional raonable.
La primera de les metodologies presentades, denominada AUC-RF, es basa en un
me`tode de classificacio´ a`mpliament utilitzat en el context de les te`cniques d’apre-
nentatge automatitzat denominat Random Forest (RF). L’algorisme AUC-RF im-
plementa una seleccio´ de variables cap a enrere basada en l’optimitzacio´ de les corbes
ROC del RF que permet identificar conjunts de marcadors gene`tics amb el major
valor predictiu sobre el risc a la malaltia.
Un RF proporciona una ordenacio´ de les variables predictores sobre la base d’algunes
de les mesures d’importa`ncia que el me`tode te´ implementades. Les dues mesures me´s
utilitzades so´n el mean decrease accuracy (MDA) i el mean decrease Gini (MDG).
En aquesta tesi presentem un treball en el que hem explorat l’estabilitat i la ro-
bustesa d’aquestes dues mesures d’importa`ncia. Els resultats d’aquest estudi posen
de manifest que el MDA e´s molt inestable i que el MDG proporciona uns ra`nquings
me´s adequats de les variables predictores que realment estan associades amb la vari-
able resposta. Aquest resultat justifica que a la metodologia AUC-RF utilitzem la
mesura d’importa`ncia MDG.
La segona metodologia proposada, denominada Optimal AUC, es basa en el concepte
de corbes ROC o`ptimes. L’objectiu torna a ser l’obtencio´ de conjunts de variables
gene`tiques amb la ma`xima capacitat predictiva, en aquest cas basant-nos en la
combinacio´ o`ptima de variables sobre la base de mesures de rao´ de versemblanc¸a.
En aquest cas l’algorisme que proposem realitza una seleccio´ de variables cap a
endavant que permet identificar interaccions gene`tiques d’ordre alt, e´s a dir, amb
un nombre elevat de variables, i possible des del punt de vista computacional.
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Un altre aspecte important que abordem en aquesta tesi e´s la simulacio´ de dades que
compleixin certes propietats similars a dades reals. Els estudis de simulacio´ tenen
molta importa`ncia en el desenvolupament i avaluacio´ de noves metodologies perque`
permeten analitzar la seva pote`ncia i efectivitat en conjunts de dades pels quals
es coneix quin hauria de ser el resultat correcte a obtenir, permeten comparar els
resultats obtinguts amb altres te`cniques i permeten analitzar com es veu afectada
l’efectivitat de la metodologia en variar els para`metres de simulacio´. Amb aquest
propo`sit, hem desenvolupat un conjunt de funcions d’R per simular les dades de
genotips i la variable resposta associada en base a models de risc.
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Introduction
Common diseases such as cancer, diabetes, Alzheimer’s or cardiovascular disease are
caused by the combination of multiple genetic and environmental factors. Under-
standing the effects of genes and environmental factors on the development of these
complex diseases is a major aim of genetic epidemiology.
In the last few years a large number of association studies have been carried out with
the goal of studying the inherited genetic basis of common diseases. A common study
design for exploring the genetic basis of human diseases is a case-control study where
single nucleotide polymorphisms (SNPs) are genotyped and differences in genotype
frequencies between cases and controls are analyzed. An SNP is a polymorphic single
nucleotide locus in the genome DNA where different variants (alleles) are observed
among the individuals in a population. SNPs are the most simple and common
form of genetic variation among individuals. Throughout the human genome there
are more than 10 million SNPs and the variation in these polymorphic loci would
explain an important part of our individual susceptibility to disease or the different
individual responses to treatments. Most SNPs have two possible alleles denoted by
an uppercase letter (for example ”A” or ”B”) and a lowercase letter (”a” or ”b”).
Usually, the uppercase denotes the ancestral allele or just the most frequent allele in
the population. Since the human genome is diploid, that is, the DNA is duplicated
in each cell of an individual, this yields to three possible genotypes per SNP: ”AA”
1
2 Introduction
Table 1: Genotype codification of a SNP.
Genotype X genotype frequencies
AA 0 pAA
Aa 1 pAa
aa 2 paa
for the common homozygous subjects, ”Aa” for the heterozygous subjects and ”aa”
for the variant homozygous subjects. From a statistical point of view an SNP can
be thought of as a categorical variable X with three different categories that can be
recoded numerically as the number of minor alleles (”a”), that is, zero for ”AA”,
one for ”Aa” and two for ”aa” (Table 1).
The number of genotyped SNPs for each individual varies from hundreds in candi-
date gene studies to above 1 million in genome-wide association studies (GWAS). In
candidate gene studies SNPs are genotyped in a set of genes that are thought to have
some relationship with the disease. Instead, GWAS are designed to cover most of
the human genetic variation by genotyping SNPs across the whole genome without
any prior hypothesis of causality. GWAS are indirect association studies where the
genotyped SNPs act as markers for the nearby region; it is assumed that an associ-
ated SNP will be either a disease-causing variant or will be in linkage disequilibrium
(LD) with an unmeasured disease-causing variant. Linkage disequilibrium (LD) is
a population genetics concept that reflects the non-random association of alleles in
two loci. In other words, LD appears when a particular allele at one locus is found
together with a specific allele at a second locus more often than expected if the two
loci were segregating independently in the population.
So far, many genes and genetic variants associated with disease risk have been identi-
fied. However, these well established variants only explain a small proportion of the
inferred genetic contribution of disease and discovering the rest of genetic variants
3remains a major challenge. The success of genetic association studies depends on
both biological and statistical factors: small size effects of individual variants, non-
additive multi-factor effects and linkage disequilibrium (LD), among others, may
affect the power of the specific study design and the statistical approach chosen for
analysis. The genetic architecture of the disease, controlled by high-penetrant muta-
tions, rare disease-causing variants, common susceptibility alleles or a combination
of these situations, may also play an important role in the success of association
studies.
Though complex diseases are known to be caused by the joint effect of multiple
genetic and environmental factors, the usual practice in genetic association studies
is a marginal analysis where each genetic marker is tested separately for association
with the disease. This marginal strategy is not very powerful since each genetic
variant is expected to have a very small marginal effect, only detectable with very
large sample sizes. Indeed, most associated variants detected up to now in GWAS
have small effect sizes with odds-ratios of disease for the risk allele typically around
1.2 (Wray et al., 2007). Furthermore, this marginal analysis strategy does not
take into account possible interactions between the genetic factors, also known as
epistasis. Genes do not act in isolation but instead their function depends on many
other genes in a network or pathway that interact in a complex way. Thus, ignoring
genetic interactions is an important limitation of the marginal analysis strategy
which can only be viewed as a preliminary step of the gene identification process
(Cantor et al., 2010).
This thesis is the result of my participation in several projects in the Bioinformatics
and Medical Statistic group at the University of Vic - Central University of Cata-
lonia. In collaboration with Dr. Nu´ria Malats (CNIO) we have been involved in
the Spanish Bladder Cancer/EPICURO study, one of the largest studies on bladder
cancer aiming at identifying genetic and environmental factors related to the etiology
and progression of bladder cancer. On the other hand, in collaboration with Dr.
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Enric Bofill and Pere Roura (Consorci Hospitalary de Vic) we have participated in
an Alzheimer’s disease (AD) study focused on the identification of genetic variants
in the reelin pathway associated with a modification of AD risk. In chapter 1 we
introduce the data sets from these two studies, on bladder cancer and Alzheimer
disease, which have motivated different parts of the present thesis.
From a methodological point of view, the goal of this thesis is the development of
new powerful methods for the identification of genetic interactions (epistasis anal-
ysis) or the improvement of existing methodologies. In this work we use the term
genetic interactions or epistasis in a rather wide sense referring to nonlinear joint ef-
fects that are not captured by a model that only considers additive marginal effects.
Several statistical methods have been proposed for epistasis analysis. From exhaus-
tive searches using regression models including interactions (Marchini et al., 2005)
to data-mining methods such as the Multi-Dimensional Reduction Method (Ritchie
et al., 2001), the Model-Based Multi-Dimensional Reduction method (Calle et al.,
2010, 2008), or approaches based on Random Forest (Bureau et al., 2005) and Sup-
port Vector Machine (Wei et al., 2009). An overview on this topic is given by Van
Steen (2012). The methods proposed in this thesis are related to the Random Forest
(chapters 3 and 4) and to the optimal ROC curve (chapter 5).
Before these developments are presented, we describe in chapter 2 some concepts
and strategies for simulating data sets from a case-control genetic study with epis-
tasis. We review two genetic disease risk models for independent genetic markers
and a binary outcome (disease status) and describe how to use these models for
simulating high-order genetic interactions. We also describe how to transform the
binary outcome into a continuous or a time-to-event phenotype. We provide R func-
tions for the proposed simulation strategies. These simulation studies are useful for
exploring the accuracy, power and improvement of the new proposed methods for
epistasis analysis.
5In chapters 3 and 4 we centre on the Random Forest (RF) methodology, a clas-
sification algorithm developed by Leo Breiman (Breiman, 2001) consisting of the
aggregation of multiple classification trees generated from bootstrap samples. Ran-
dom Forest can be used for ranking variables according to a measure of importance
and this ranking can be used for feature selection. In chapter 3 we explore the
stability and robustness of two importance measures provided by RF, mean de-
crease accuracy (MDA) and mean decrease Gini (MDG). In this work we show that
MDA is very unstable and that MDG provides better rankings for causal variants.
This part of the thesis is published in Calle and Urrea (2011). In chapter 4 we
propose a new strategy for variable selection using Random Forest. The proposed
algorithm, namely AUC-RF, computes the Receiver Operating Curve (ROC) as-
sociated to the Random Forest, uses the area-under-the ROC curve (AUC) as the
predictive accuracy of the Random Forest and implements a backward elimination
process for selecting the set of variables with the highest AUC value. The goal of
this chapter is two-fold: establish AUC as a preferable accuracy measure for Ran-
dom Forests compared to the usual classification error rate and to provide a new
selection algorithm based on the AUC. In particular, we show that the use of the
classification error is especially inappropriate when dealing with unbalanced data
sets. The new method is published in the Human Heredity journal (Calle et al.,
2011) and the algorithm is publicly available as an R package, named AUCRF, at
http://cran.r-project.org/web/packages/AUCRF and the package documentation
can be found in appendix B.
Most statistical methods for epistasis analysis are able to scan for second or third
order interactions but, since they are very computationally demanding, they become
unfeasible for exploring higher order interactions when the number of variables to
explore is large, as is usually the case. In chapter 5 we propose a new strategy
for exploring higher order interactions. The method is based on the concept of
the likelihood ratio score and optimal ROC curves and follows a process of forward
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selection to obtain the subset of factors with the highest joint predictive accuracy.
The algorithm, referred to as Optimal AUC, is computationally feasible in a large
variable context.
In summary, the major contributions presented in this thesis are two new methodolo-
gical strategies, the AUC-RF and the Optimal AUC algorithms, for the identification
of genetic variants in association studies in the presence of epistasis. The develop-
ment of these methodologies and the need to assess their accuracy has led to two
also remarkable contributions, an in depth study of the stability of the importance
measures of the Random Forest methodology and a new strategy for simulating
epistasis.
CHAPTER 1
Bladder Cancer and Alzheimer’s Disease Studies
This chapter presents a description of the data sets that have been used and which
have served as motivation for the different sections of this thesis. The first data set
corresponds to the Spanish Bladder Cancer/EPICURO study and the second one
to the Alzheimer’s Disease study.
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1.1 The Spanish Bladder Cancer/EPICURO Study
Bladder cancer is the fifth most commonly diagnostic cancer type in Europe. In
Spain about 8.000 new cases are diagnosed each year, and is one of the cancers with
a higher prevalence. It is a chronic disease with a survival rate at five years of 70%,
which requires strict medical lifelong checks and has a considerable impact on the
quality of life of patients. It is one of the cancers with higher health care costs per
patient.
The main causes of risk for bladder cancer are tobacco smoking and certain occupa-
tional exposure to carcinogens. It is known that men have a higher risk of developing
the disease than women and that this risk increases with age.
Several studies also suggest genetic causes that may have some influence on the
susceptibility to bladder cancer, as it has detected an increased risk in patients with
family history of bladder cancer.
The study of genetic factors associated with susceptibility to this cancer has mainly
focused on genes encoding enzymes involved in xenobiotic metabolism (deactivation
and removal mechanism of a type of potentially harmful substances), but other
types of processes are also of interest as the xenobiotic transport, apoptosis (cell
death genetically regulated), cell cycle control, angiogenesis (physiological process
of formation of new blood vessels from preexisting vessels), tumor progression or
inflammation process.
The Spanish Bladder Cancer/EPICURO Study (SBCS) was initiated in 1997 with
the purpose of advancing knowledge of this cancer for improving prevention, prog-
nosis and treatment. Its main objectives are to evaluate the risk of bladder cancer in
relation to environmental and occupational exposures, to evaluate the role of lifestyle
factors in their etiology and to evaluate the effects of genetic susceptibility markers
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on the risk of bladder cancer and their interaction with environmental exposures.
The SBCS is a case-control study conducted in 18 hospitals from 5 areas in Spain
(Asturias, Barcelona metropolitan area, Valle`s/Bages, Alicante, and Tenerife). Eli-
gible cases were aged 21-80 years and had newly diagnosed, histologically confirmed
carcinoma of the urinary bladder during 1998-2001. Patients who had a previous
diagnosis of cancer of the lower urinary tract (i.e. bladder,renal pelvis, ureters, or
urethra) were not eligible for the study, as were patients with bladder tumors that
were secondary to other malignancies. Controls were selected from patients admitted
to participating hospitals with diagnoses thought to be unrelated to the exposures
of interest, such as tobacco use. Controls were individually matched to the cases
for age at interview within 5-year categories, sex, ethnic origin, and region. After
having accepted to participate, subjects gave information on their past exposure to
several environmental risk factors and provided blood/saliva as a source of genomic
DNA.
Participants were classified as never smokers if they had smoked fewer than 100
cigarettes in their lifetime and ever smokers otherwise. Ever smokers were further
classified as regular smokers if they had smoked at least 1 cigarette per day for 6
months or longer and occasional smokers otherwise. Current smokers were defined
as those regular smokers who had smoked within a year of the reference date; indi-
viduals who had smoked regularly but who had stopped smoking more than 1 year
before the reference date were defined as former smokers.
In this thesis we use a data set from SBCS consisting of a total of 2299 individuals
(1150 controls and 1149 cases). Four environmental variables (gender, region, age
and smoking status) and 267 genetic variables. Table 1.1 describes the distribution
of individuals with respect to the variables gender, region, age that were used for
matching cases and controls.
Table 1.2 shows the distribution of cases and controls by exposure to smoking, which
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Table 1.1: SBCS. Distribution of individuals with respect to gender,
region, age and exposure to smoking.
Variable Category Cases Controls Total
Gender Male 1004 (87.3%) 1002 (87.2%) 2006 (87.3%)
Female 146 (12.7%) 147 (12.8%) 293 (12.7%)
Age < 55 171 (14.9%) 194 (16.9%) 365 (15.9%)
55-64 240 (20.9%) 280 (24.4%) 520 (22.6%)
65-69 254 (22.1%) 263 (22.9%) 517 (22.5%)
70-74 254 (22.1%) 226 (19.7%) 480 (20.9%)
≥ 75 231 (20.0%) 186 (16.1%) 417 (18.1%)
Region Barcelona 209 (18.2%) 232 (20.2%) 441 (19.2%)
Valle`s Occidental/Bages 180 (15.7%) 182 (15.8%) 362 (15.7%)
Alicante 85 ( 7.4%) 82 ( 7.1%) 167 ( 7.3%)
Tenerife 211 (18.3%) 191 (16.6%) 402 (17.5%)
Asturias 465 (40.4%) 462 (40.3%) 927 (40.3%)
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Table 1.2: SCBS. Distribution of cases and controls
by exposure to smoking.
Category Cases Controls
Non-smokers 159 (32.0%) 338 (68.0%)
Occasional smokers 50 (36.2%) 88 (63.8%)
Former smokers 447 (51.1%) 428 (48.9%)
Current smokers 494 (62.6%) 295 (37.4%)
is the main risk factor associated with bladder cancer. We observe a ratio of twice
as many cases than controls among smokers and this ratio is reversed among non-
smokers and former smokers.
The genetic variables corresponds to 267 SNPs genotyped in a total of 106 genes
in the inflammatory pathway. Table 1.3 describes the distribution of SNPs in the
different genes.
1.2 Alzheimer Disease Study
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases,
its prevalence ranges between 20% and 40% in developed countries. The hallmarks
of Alzheimer’s disease is the extracellular accumulation of β-amyloid plaques, hard
and insoluble plaques of protein fragments, and the intracellular accumulation of
neurofibrillary tangles, insoluble twisted fibers found inside the brain’s cells.
We were involved in the AD project ”Genotypes associated with synaptic Neuro-
plasticity in Alzheimer’s disease” in collaboration with Dr. Enric Bofill from the
Neurology Service and Pere Roura (Consorci Hospitalari de Vic). The project,
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Table 1.3: SBCS. Distribution of SNPs in the different genes.
Gene Name SNPs Gene Name SNPs Gene Name SNPs
ABCA1 5 EPHX2 1 IRF3 2
ABCA7 2 EXO1 2 JAK3 3
ABCC4 2 FAS 3 LEPR 4
AKR1C3 10 FASLG 1 LITAF 2
AKT1 1 FCGR2A 1 LTA 2
ALOX12 1 FOS 3 MASP1 8
ALOX15 1 GATA3 6 MBL2 8
ALOX5 5 GDF15 2 MPO 2
APOA2 3 GSK3B 7 MSH2 7
ARHGDIB 2 HFE 3 MX1 5
BCL6 4 ICAM1 4 NBS1 2
BIRC2 1 IFNAR2 1 NCF2 2
BPI 1 IFNG 1 NFKB1 3
CARD15 3 IFNGR1 2 NINJ1 2
CASP3 4 IFNGR2 2 NOS2A 3
CASP8 2 IL10 5 OPRD1 2
CBR1 2 IL10RA 2 PARP4 3
CCL5 2 IL12A 1 PTGS1 1
CCND3 1 IL12B 1 PTGS2 4
CCR2 2 IL13 2 RHOA 1
CCR3 2 IL15 3 SCARB1 5
CCR5 2 IL15RA 4 SELE 1
CD14 1 IL1A 2 SFTPD 2
CD4 1 IL1B 3 SLAMF1 3
CD40 1 IL1RN 2 TFF1 1
CD80 3 IL2 2 TFF3 1
CD81 1 IL3 1 TGFB1 2
CD86 2 IL4 2 TGFBR1 2
CFH 5 IL4R 5 TLR2 3
CRP 2 IL6 1 TLR4 1
CSF1R 2 IL6R 1 TNF 5
CSF2 1 IL7R 2 TNFRSF10A 2
CSF3 2 IL8 1 TNFRSF1A 1
CTLA4 6 IL8RA 1 TNIP1 1
CX3CR1 2 IRF1 1 VCAM1 1
XBP1 2
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funded by the UNNIM - Obra Social (UNNIM grant in health sciences 2011), was
aimed to explore the role of the genetic variability in the Reelin signaling pathway
in Alzheimer’s disease. The Reelin signaling pathway contributes to the formation
of synaptic circuits in the central nervous system and interacts with ApoE protein,
whose ApoE-4, allele is the best established genetic risk factor for late-onset AD
(Rice and Curran, 2001; Seshadri et al., 1995). The specific goals of the study were
to analyze any association between the genes involved in the Reelin signaling path-
way with Alzheimer’s disease, identifying genetic risk profiles of SNPs in genes of
the Reelin pathway and to analyze potential interactions between ApoE genotypes
and those SNPs.
With this purpose we used the data from a publicly available GWAS (Genome Wide
Association Study) conducted by Reiman et al. (2007). The dataset corresponds to
a case-control study with 1411 subjects (861 cases and 550 controls) and 502, 627
SNPs genotyped. Since we focus in the Reelin pathway, we extracted 682 SNPs
which lie within 32 genes of the Reelin signaling pathway. Table 1.4 describes the
distribution of SNPs in the different genes. The dataset also provides an indicator
variable of whether the individual is carrying the apolipoprotein variant ApoE-4.
The dataset was available for download from http://public.tgen.org/tgen.org/
supplementarydata/neurogenomics/supplementarydata/GAB2.
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Table 1.4: AD. Distribution of SNPs in the diferent genes.
SNPs in SNPs in SNPs in SNPs in
Gene Chm gene promotor Gene Chm gene promotor
ABL1 9 27 0 LRP2 2 43 1
ABL2 1 6 2 PIK3R1 5 8 2
APOE 19 CDK5R1 17
APOER2 1 11 0 CDK5R2 2
APP 21 49 1 TP73 1 4 0
BDNF 11 5 1 AKT1 14 2 1
CAMK2A 5 10 1 PLK2 5 1 0
CASK X PSEN1 14 4 0
CDC42 1 10 2 PSEN2 1 5 1
CDK5 7 4 0 RAC1 7 5 0
CNR1 6 6 2 RELN 7 80 2
DAB1 1 251 1 RHO 3 1 1
EMX2 10 0 1 RHOA 3 0 4
EPHA1 7 1 2 SHIP 2 18 0
FYN 6 36 1 SRC 20 4 0
GSK3B 3 7 0 TAU 17 31 0
ITGA3 17 4 6 TBR1 2 2 4
LDLR 19 4 0 VLDLR 9 5 2
CHAPTER 2
Simulation of genetic risk profiles for binary,
continuous and time-to-event phenotypes
Simulation studies in genetic epidemiology research are essential for evaluating the
accuracy, power and potential improvement of new methodologies for exploring the
genetic component of a disease. In this chapter we review two genetic disease risk
models for independent genetic markers and binary outcome (disease status) and
describe how to use these models for simulating high-order genetic interactions. We
also describe how to transform the binary outcome in a continuous or time-to-event
phenotype. We provide R functions for the proposed methods.
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2.1 Introduction
Simulation studies play an important role in genetic epidemiology research. They
are essential for evaluating the accuracy, power and potential improvement of new
methodologies for exploring the genetic component of a disease. The simulation
of such datasets involves two steps, the simulation of the genetic markers and the
simulation of the phenotype. Here we center on the case where the genetic markers
are single nucleotide polymorphisms (SNPs). The simulation of genotypes requires
the specification of allelic and genotype frequencies and possible correlations between
the genetic variables (LD). The simulation of the phenotype, which can be binary,
continuous or a time-to-event variable, requires the specification of a disease risk
model that relates the genotypes with the phenotype.
Though epistasis analysis is one important research topic, most disease risk models
considered in simulation studies assume independence among causal SNPs or, at
best, incorporate second-order interactions by adding the corresponding interaction
terms in the model. Modeling higher order interactions in this parametric way is
complicated. In this chapter, we illustrate these concepts, review two genetic disease
risk models for independent genetic markers and binary outcome (disease status) and
describe how to use these models for simulating high-order genetic interactions. We
also describe how to transform the binary outcome into a continuous or time-to-
event phenotype. In appendix A we provide the R language code of the functions
for the proposed methods.
There exist several sophisticated methods and programs for simulating genotypes
that reproduce the intrinsic architecture of the human genome in a very realistic
manner (Li and Li, 2008; Wright et al., 2007). They provide simulated datasets with
realistic patterns of LD and allele frequencies by resampling from human genome
variation databases, as Hapmap (I.H.C., 2003). This strategy consists on select-
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ing a set of SNPs in an LD block at the Hapmap database and, based on their
genotype information, estimate the haplotypes frequencies and then generate the
individual genotypes by matching randomly pairs of simulated haplotypes. More
sophisticated models and software are available for generating simulated data that
closely resemble real data, such as HAPGEN2 software that simulates haplotypes
by conditioning on a reference set of population haplotypes and an estimate of the
fine-scale recombination rate across the region, so that the simulated data has the
same LD patterns as the reference data, or the simulation program COSI which
implements a coalescent model (Schaffner et al., 2005).
Although these methods are very useful for evaluating the performance of a new
approach in a realistic situation, in initial phases of a new methodological develop-
ment it can be convenient to explore the performance of the new method in a simpler
and more controlled framework. With this aim, in section 2.2 we describe simple
methods for simulating genotypes where the user can control the allele frequencies
and the degree of linkage disequilibrium (LD) between variables. Sections 2.3 to 2.5
are dedicated to the simulation of phenotypes. In section 2.3 we describe two al-
ternative models of genetic disease risk that have been proposed in the literature,
the multiplicative model and the multiplicative odds of risk model (Janssens et al.,
2006; Wray and Goddard, 2010; Wray et al., 2007). In section 2.4 we propose a
strategy for simulating a binary phenotype (disease status) given a specific genetic
profile and a risk model. In these simulations the causal genetic variants may ei-
ther act independently on the risk of disease or have a joint nonlinear interacting
effect. In section 2.5 we show how to transform a simulated binary phenotype into
a continuous or a time-to-event variable. Finally, in section 2.6 we provide some
examples to illustrate the use of a set of R functions that we have developed for this
purpose.
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2.2 Simulation of genotypes
We consider diallelic loci, for instance, Single Nucleotide Polymorphisms (SNPs). As
mentioned in the introduction, we denote by A the wild-type or major allele and by
a the variant or minor allele. Let p denote the frequency of the variant allele a. We
assume that the genotypes are in Hardy-Weinberg equilibrium (HWE), that is, the
genotype frequencies for the three genotypes (AA, Aa, aa) are (1− p)2, 2p(1 − p)
and p2, respectively.
2.2.1 Simulation of independent SNPs
The simulation of independent SNPs can be easily implemented. From a statistical
point of view a SNP is a categorical variable with three different categories that can
be recoded numerically as the number of minor alleles in the locus, that is, zero for
AA, one for Aa and two for aa. The individual genotypes for a SNP in a sample are
generated as i.i.d. realizations of a random variable following a binomial distribution
with size equal to 2 and probability of success equal to p, the frequency of the minor
allele.
2.2.2 Simulation of SNPs in LD blocks
Linkage disequilibrium (LD) is a population genetics concept that reflects the non-
random association of alleles in two loci. In other words, LD appears when a partic-
ular allele at one locus is found together with a specific allele at a second locus more
often than expected if the two loci were segregating independently in the population.
There are different measures to characterize the strength of LD between two loci.
For two diallelic loci with minor alleles a and b and minor allele frequencies pa and
2.2. Simulation of genotypes 19
pb, respectively, the most simple and intuitive measure of LD is D, the difference
between the observed haplotype frequencies and the expected frequencies assuming
independence (D = pAB − pA · pB = pab − pa · pb). A standardized version of D is
given by the correlation coefficient defined as r = D/
√
pA · pa · pB · pb.
As mentioned before, the goal of the following proposal for simulating SNPs in LD
is not to obtain a realistic genetic dataset that mimics the LD structure in the
human genome. Instead, our goal is to simulate genetic data sets of SNPs including
correlations between them in a controlled manner, where the allele frequencies and
the degree of LD between SNPS are specified by the user.
Given a first SNP (SNP1), we can simulate a second SNP (SNP2) with a specified
LD correlation r with SNP1 by sampling from the conditional distributions of the
genotypes of SNP2 given the genotypes of SNP1. These conditional distributions
can be derived from the definition of D assuming HWE, and are given by:
P (BB | AA) = (pA · pB +D)2 / pA2,
P (Bb | AA) = 2(pA · pB +D)(pA · pb −D) / pA2,
P (bb | AA) = (pA · pB −D)2 / pA2,
P (BB | Aa) = (pA + pB +D)(pa · pb −D) / (pA · pa),
P (Bb | Aa) = [(pA + pB +D)(pa · pb +D) + (pA + pB −D)(pa · pb −D)] / (pA · pa),
P (bb | Aa) = (pA + pB −D)(pa · pb +D) / (pA · pa),
P (BB | aa) = (pa · pB −D)2 / pa2,
P (Bb | aa) = 2(pa + pB −D)(pa · pb +D) / pa2,
P (bb | aa) = (pa · pb +D)2 / pa2.
Since D = r
√
pA · pa · pB · pb , the conditional distributions of the genotypes of SNP2
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given the genotypes of SNP1 are determined by the correlation coefficient r and the
allele frequencies.
Thus, a simple method for simulating a set of SNPs that form a haplotype block
of SNPs in LD is to start by simulating a first SNP that is used as a reference and
then generate consecutively the other SNPs in the block according to a specified LD
correlation with the reference SNP and using the above conditional distributions.
This has the limitation that we can only control the correlation of each SNP in the
block with a reference SNP, but not the correlation among the rest of SNPs. In
this sense, it does not perfectly mimic genotype data, but it is a way to introduce
structures of LD in the data that are controlled with just one parameter.
2.3 Multi-locus models of disease risk for a
binary phenotype
Once the genotypes of M SNPs have been generated for a sample of individuals, we
will simulate the phenotype, in this case, a binary phenotype Y denoting diseased
(Y = 1) and non-diseased (Y = 0). We assume that a subset of the total available
SNPs are associated with disease (for simplicity we will call them causal or risk
SNPs) and the rest are not associated with Y (null SNPs). We denote by m the
number of causal SNPs with m ≤M .
The simulation of Y requires the specification of a genetic disease risk model, a
model that describes the individual genetic risk of an individual on the basis of
his/her genotypes at the m genetic causal loci. We describe below two alternative
multi-locus disease models, both multiplicative risk models in different scales. The
first model, referred simply as multiplicative risk model, is multiplicative in the risk
scale while the second, referred as odds of risk model, is multiplicative in the odds
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scale.
For each causal loci i = 1, . . . ,m we denote by ai and Ai the variant and wild-type
alleles, respectively, and pi the frequency of the variant allele. We assume HWE.
For simplicity of explanation we will describe the models under an additive mode
of inheritance for each locus where ri is the relative risk of the heterozygous group
Aiai with respect to the reference group AiAi and r
2
i is the corresponding relative
risk for the minor homozygous genotypes aiai, that is:
ri = P (Y = 1 | Aiai)/P (Y = 1 | AiAi),
r2i = P (Y = 1 | aiai)/P (Y = 1 | AiAi).
2.3.1 Multiplicative risk model
The multiplicative risk model for independent loci under an additive mode of inher-
itance assumes that each risk allele increases multiplicatively the baseline genetic
risk of disease. Given a genomic profile (G1, . . . , Gm) and Y , the indicator of disease,
the multiplicative model can be expressed as:
P (Y = 1 | G1, . . . , Gm) = g0
m∏
i=1
rXii (2.1)
where Xi is the number of risk alleles, 0, 1, or 2, at the ith locus and g0 = P (Y =
1 | G1 = A1A1, . . . , Gm = AmAm) = P (Y = 1 | X1 = · · · = Xm = 0) is the baseline
disease risk, that is, the disease risk of those individuals with no minor allele in the
m loci.
If we assume that the relative risk at each loci is the same, say r, then the multi-
plicative model reduces to
P (Y = 1 | G1, . . . , Gm) = g0 · rX (2.2)
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where X = X1 + · · · + Xm is the total number of minor alleles across the m loci
(Wray et al., 2007).
Under model (2.2) and assuming equal allele frequency p across loci, the prevalence
of the disease (K) and the broad sense heritability (h2) can be explicitly expressed
as a function of the number of loci, m, the minor allele frequency, p, the relative
risk, r, and the baseline risk, g0:
K = P (Y = 1) = g0(1 + p(r − 1))2m (2.3)
and
h2 =
K
(1−K) ·
(1 + p(r2 − 1))2m
(1 + p(r − 1))4m − 1 (2.4)
where the heritability, h2, indicates the fraction of the phenotype variability that can
be attributed to the genetic variation or the proportion of disease cases attributable
to genetic effects (Wray et al., 2007).
Expressions (2.3) and (2.4) can also be used to derive the number of risk loci un-
derlying a complex disease, that is, the number of loci that explains the estimated
prevalence and heritability of a given disease for different values of the risk allele
frequency and the relative risk:
n =
1
2
· ln[h
2 + (1− h2)K]− ln(K)
ln[1 + p(r2 − 1)]− 2 ln[1 + p(r − 1)] . (2.5)
This expression, together with the low relative risk observed in empirical studies,
suggests that most common diseases might be affected by a large number of loci
(Wray et al., 2007).
The multiplicative risk model is intuitive and attractive for its simplicity; however,
it has a major drawback: equations (2.1), (2.2) or (2.3) are not restricted to be in
the plausible range of values of a probability and under some combinations of model
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parameters the probability of disease can take values larger than 1 (Wray et al.,
2010). For this reason, alternative models such as the odds of risk model have been
proposed (Janssens et al., 2006; Wray et al., 2010).
2.3.2 Multiplicative odds of risk model
The multiplicative odds of risk model for independent loci (Janssens et al., 2006;
Wray and Goddard, 2010) assumes a multiplicative model for the likelihood ratios
(LR). In other words, the model assumes that the LR of a genetic profile can be
obtained by multiplying the LRs of the individual genotypes:
LR(G1, . . . , Gm) =
m∏
i=1
LRi (2.6)
where
LR(G1, . . . , Gm) =
P (G1 = g1, . . . , Gm = gm | Y = 1)
P (G1 = g1, . . . , Gm = gm | Y = 0)
and
LRi =
P (Gi = gi | Y = 1)
P (Gi = gi | Y = 0) , i = 1, . . . ,m.
The odds of disease, P (Y = 1 | G1, . . . , Gm) / [1 − P (Y = 1 | G1, . . . , Gm)], is
obtained by multiplying the prior odds by the likelihood ratio (LR). The prior odds
can be calculated from the prevalence of disease as K/(1 −K). Thus, the odds of
disease is:
odds = prior odds · LR(G1, . . . , Gm) = K
(1−K) · LR(G1, . . . , Gm).
Under the multiplicative odds risk model, the odds of disease is given by
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odds =
K
(1−K) ·
m∏
i=1
LRi. (2.7)
On the other hand, the individual risk of disease given a genomic profile can be
expressed in terms of the odds of disease:
P (Y = 1 | G1, . . . , Gm) = odds
1 + odds
. (2.8)
Unlike the multiplicative model, this expression guarantees that under the odds of
risk model the probability of disease takes values in [0, 1].
The multiplicative odds of risk model is described in Janssens et al. (2006) and
expression (2.6) is further developed in terms of odds-ratios. Here we describe the
model in terms of relative risks.
Table 2.1: Joint probability distribution of genotypes, Gi and the disease
indicator Y where p denotes the frequency of the variant allele A.
G X Y = 1 Y = 0 P (G)
AA 0 p01 p00 f0 = (1− p)2
Aa 1 p11 p10 f1 = 2p(1− p)
aa 2 p21 p20 f2 = p
2
(Total) K 1−K 1
The LR at each single loci, LRi = P (Gi = gi | Y = 1) / P (Gi = gi | Y = 0), can be
obtained from the joint probability distribution of genotypes, Gi, and the disease
indicator Y , shown in Table 2.1, where the values in the table can be derived from
the disease model parameters, prevalence, K, risk allele frequency, p, relative risk,
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r, and are given by the following expressions:
p01 = K · f0 / (f0 + r · f1 + r2 · f2),
p11 = p01 · r · f1 / f0,
p21 = p01 · r2 · f2 / f0,
p00 = f0 − p01,
p10 = f1 − p11,
p20 = f2 − p21.
Then, the likelihood ratios at each locus for the three possible genotypes are:
LR(X = 0) =
P (G = AA | Y = 1)
P (G = AA | Y = 0) =
p01 · (1−K)
p00 ·K ,
LR(X = 1) =
P (G = Aa | Y = 1)
P (G = Aa | Y = 0) =
p11 · (1−K)
p10 ·K ,
LR(X = 2) =
P (G = aa | Y = 1)
P (G = aa | Y = 0) =
p21 · (1−K)
p20 ·K .
2.4 Simulation of disease status from a genetic
profile
Once the genotypes have been generated we proceed with the simulation of the
response variable Y , the indicator of the presence or absence of disease. In sub-
section 2.4.1 we describe how to simulate disease status when the risk SNPs are
independent. Instead, in subsection 2.4.2 we propose a new strategy for simulating
the response variable from a set of interacting SNPs.
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2.4.1 Simulation of disease status from independent SNPs
For each combination of genotypes of the m risk loci, (G1, . . . , Gm), we obtain the
individual risk of disease P (Y = 1 | G1, . . . , Gm) from equation (2.1), if we assume
the multiplicative risk model, or from equation (2.8), if we consider the multiplicative
odds of risk model. For these two models to be valid it is necessary that the m risk
loci are mutually independent. We assume that each risk locus is in a different LD
block but they may be in LD with other non-susceptible loci. Then, as in Janssens
et al. (2006), we generate a value u from a Uniform (0, 1) distribution and if the
individual risk of disease is larger than u we set Y = 1 for this individual and Y = 0,
otherwise. That is, Y = 1 if P (Y = 1|G1, . . . , Gm) > u and Y = 0, otherwise.
2.4.2 Simulation of high-order genetic interactions
associated with disease risk
One of the challenges of genetic association studies is the identification of interactions
between genetic variants that could explain part of the genetic risk that remains
unknown. Many methods have been recently proposed for epistasis analysis and the
performance of these methods should be explored and compared through simulation
studies. Here we propose a simple strategy for simulating high-order interactions.
Note that we use the term interaction in a very broad sense, meaning that the joint
effect of a set of SNPs does not correspond with the aggregation (multiplicatively
or additively) of the individual effects of each SNP.
Given m loci, an interaction of order m associated with disease risk can be simulated
by considering a latent variable L that assigns a value 0, 1 or 2 to each multi-locus
genotype (G1, . . . , Gm) and this value corresponds to the disease risk of the multi-
locus genotype: 0 for low risk, 1 for intermediate risk and 2 for high risk of disease.
We denote by p0, p1 and p2 the proportion of multi-locus genotypes in each risk group
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(below is described how we set these proportions). The values of L, 0, 1 and 2, can
be randomly assigned to the different multi-locus genotypes in order that the joint
multilocus effect does not correspond with the aggregation of the individual effects.
This procedure might be useful if we want to explore the performance of a method
for identifying genetic interactions in the absence of main effects. Alternatively, the
risk groups can be assigned according to some function of the genotypes, for instance,
the score function S =
∑m
i=1Xi that counts the total number of variant alleles for
this genotype. In this case the joint effect will correspond to the accumulation of
individual effects.
The newly generated latent variable L, that takes values 0, 1 and 2, is then treated
as if it was a SNP for generating the phenotype Y following the strategy described
in subsection 4.1. That is, we obtain the individual risk of disease given the latent
variable, P (Y = 1 | L), from equation (2.1) or (2.8), depending on the assumed
disease model, and from this probability we generate Y as described above. This
requires the specification of three model parameters: disease prevalence, relative risk,
r, and frequency, p. Here r is the relative risk of individuals in the intermediate risk
group with respect to the low risk group. In this case the frequency p is not the
risk allele frequency but a parameter that we use to specify the frequency of the 3
risk groups: Given p we define the frequency of the low risk as p0 = (1 − p)2, the
frequency of the intermediate risk group as p1 = 2p(1− p) and the frequency of the
high risk group as p2 = p
2 (as if they were the genotype frequencies of a SNP in
HWE).
The disease risk phenotype can also be simulated from a set of J independent in-
teracting blocks of SNPs. For each block of SNPs j = 1, . . . , J , we create a latent
variable Lj, as described previously, and simulate the phenotype given the latent
variables, P (Y = 1 | L1, . . . , LJ), from equation (2.1) or (2.8) according to the
assumed disease model.
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2.5 From binary to continuous or survival data
Following (Gui et al., 2011), we can exploit the procedures and models described in
the previous sections for simulating continuous and time-to-event phenotypes.
Given a set of genetic variables we first generate a binary outcome Y based on a
specified disease risk model. We interpret the generated binary variable not as the
disease status indicator but as an indicator of disease risk: Y = 1 corresponds to
higher risk of disease and Y = 0 to lower risk. We specify two different distributions
for the phenotype of these two groups of risk and generate the phenotype value for
each individual according to its Y risk indicator.
For a continuous phenotype X we will typically assume two normal distributions
X1 = N(µ1, σ1) when Y = 1 and X0 = N(µ0, σ0) with µ1 > µ0 if larger values of
X increase the risk of disease. Of course, alternative distributions are possible.
For a time-to-event phenotype T we will assume the usual distributions for survival
data, for instance, the Weibull distribution. In this case, T1 ∼ Weib(α1, β1) if Y = 1
and T0 ∼ Weib(α0, β0) if Y = 0 with the parameterization Weib(a, b) corresponding
to a hazard function h(t) = b
ab
tb−1 where a is the scale parameter and b the shape
parameter. Assuming the same shape parameter beta for T1 and T2, corresponds
to assuming proportional hazards. In this case, the hazard ratio between the two
groups of individuals is equal to HR = (α1 / α2)
β. This expression is useful for
specifying the parameters of T1 and T2 given the hazard ratio.
In addition to the survival times we also need to sample censoring times for a
censoring variable C that indicates the follow-up time of each individual. We can
assume any positive distribution for C. Typical choices are the uniform distribution,
the exponential distribution and the Weibull distribution.
Then, the observed survival data consists of the pair (T ∗, δ) where T ∗ = min(T,C)
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and δ = 1{T ≤ C} indicates if the data is observed, δ = 1, or right censored, δ = 0.
The proportion of censoring is given by P (T > C) and a pre-specified censoring
proportion can be used to determine the parameters of the distribution of C.
2.6 R functions and Examples
In this section we provide some examples that illustrate the new developed R func-
tions for the different sections of this paper.
2.6.1 Function SNPgenerate
This function generates the genotypes of n individuals for a set of independent
SNPs according to the specified minor allele frequencies (MAF) as described in
section 2.2.1. For example, the syntax for simulating the genotypes of a SNP with
MAF equal to 0.3 for 100 individuals is:
SNPgenerate(n=100, maf=0.3)
The maf argument can be a vector specifying the MAF of several SNP. The length
of maf defines the number of SNPs to be simulated. The following example produces
a data set with four SNPs with specified MAFs:
SNPgenerate(n=100, maf=c(0.2, 0.3, 0.3, 0.4))
The following example generates a data set with 30 SNPs with random MAFs:
SNPgenerate(n=100, maf=runif(30, min=0.1, max=0.5))
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2.6.2 Function LDgenerate
Given a first SNP, this function generates new SNPs with specified MAFs and with
specified LD correlation with the initial SNP as described in section 2.2.2. For
example, the code for simulating a SNP with MAF equal to 0.2 and LD with snp1
equal to 0.9 is:
LDgenerate(x=snp1, r=0.9, maf=0.2)
As in the previous functions, r and maf arguments can be vectors of equal length,
and the length of these vectors determines the number of SNPs that are simulated.
Next example generates a bloc of 11 SNPs in LD with snp1, according to a decreas-
ing LD correlation sequence and random MAFs between 0.2 and 0.4:
LDgenerate(x=snp1, r=seq(from=0.9, to=0.7, length.out=11),
maf=runif(n=11, min=0.2, max=0.4))
2.6.3 Function RiskGenerate
Given a dataset of genotypes for n individuals, this function generates the individual
genetic risk and the disease status as detailed in section 2.4.1 and assuming the
multiplicative odds of risk model. The following sentence generates the individual
disease status from the genotypes in SNPdata with disease prevalence equal to 0.1
and assuming that all the SNPs in SNPdata are causal and have the same relative
risk equal to 2:
status <- RiskGenerate(data=SNPdata, RR=2, p=0.1)
We can specify a subset of SNPs to be causal using the argument data. For example,
we can simulate a dataset where SNP3, SNP10 and SNP14 are causal SNPs:
status <- RiskGenerate(data=SNPdata[,c("SNP3","SNP10","SNP14")], RR=2,
p=0.1)
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In this case, different values of RR may also be specified for each SNP, by specifying
a vector for RR of length equal to the number of SNPs:
status <- RiskGenerate(data=SNPdata[,c("SNP3","SNP10","SNP14")],
RR=c(2,1.5,1.3), p=0.1)
2.6.4 Function SNPInteract
This function simulates disease status from a set of interacting SNPs as described
in section 2.4.2. It requires the specification of the set of interacting SNPs, the
relative risk (RR), the prevalence of the disease (p) and the proportion of individuals
in the high risk group (hrp). The following R instruction will simulate the disease
status associated to an interaction of the SNPs in a data set named SNPdata, with
a relative risk equal to 1.5, a prevalence equal to 0.1, and a proportion of individuals
in the high risk group equal to 0.3:
status <- SNPInteract(data=SNPdata, RR=1.5, p=0.1, hrp=0.3)
If the interacting SNPs are only a subset of all available SNPs, the value in data
argument must be restricted. The following example illustrates the disease status
generated from an interaction among the first four SNPs:
status <- SNPInteract(data=SNPdata[,1:4], RR=1.5, p=0.1, hrp=0.3)
2.6.5 Functions Bin2Cont and Bin2Surv
As described in section 2.5, it is possible to generate a continuous or survival time
variable from a binary response Y . We have implemented two functions for doing
this. For the continuous case, function Bin2Cont transforms the binary variable
Y to a continuous variable using two normal distributions, one for individuals with
Y=0 and the other for individuals with Y=1. The mean and standard deviation of
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the two normal distributions must be specified. In the following example, the means
are equal to 40 and 60 and the standard deviations are equal to 10 in both groups:
Z <- Bin2Cont(Y, mean0=40, sd0=10, mean1=60, sd1=10)
The Bin2Surv function is similar. It transforms the binary variable Y to a time-
to-event variable T assuming two Weibull distributions, one for individuals with
Y = 0 and the other for individuals with Y = 1. The parameters of the Weibull
distribution must be specified. It is required and additional argument, tmax, that
specifies the maximum follow-up time. Censoring times C are simulated according
to a uniform distribution in the interval [0, tmax]. The output of this function is
a data frame with two variables, the observed survival time, T ∗ = min(T,C), and
the observed event indicator, 1{T ≤ C}. Below, there is an example where the
scale parameter of the two groups is equal to 40 (low risk group) and equal to 30
(high risk group) while the shape parameter is equal for the two groups (this last
condition implies proportional hazards between the two groups):
S <- Bin2Surv(Y, tmax=30, shape0=1.3, scale0=40, shape1=1.3, scale1=30)
CHAPTER 3
Stability of Random Forest Importance Measures
Genetic variants are usually ranked and selected according to their p − value ob-
tained from a single-SNP analysis. This approach ignores possible epistasis and
only captures marginal effects. An alternative is to rank the variables according to
Random Forest importance measures, these ranks would incorporate possible non-
linear effects among the variables. Random Forest provides two possible importance
measures, mean decrease accuracy (MDA) and mean decrease Gini (MDG). In this
chapter we explore the stability of these two importance measures. We illustrate
with a real and a simulated example that ranks based on the MDA are unstable
to small perturbations of the dataset while ranks based on the MDG provide more
robust results. The content of this chapter has been published as a letter to the
editor in Briefings in Bioinformatics (Calle and Urrea, 2011).
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3.1 Introduction
Random Forest (Breiman, 2001) is a popular and widely used supervised learn-
ing method consisting a large set of tree-based models (regression or classification
trees). Predictions with Random Forest are obtained by averaging the predictions
of the different trees. In addition, it provides different measures of importance for
each variable. The R package randomForest (Liaw and Wiener, 2002), available
at http://cran.r-project.org, implements this method and provides two differ-
ent importance measures, mean decrease accuracy (MDA) and mean decrease Gini
(MDG), that can be used for ranking variables and for variable selection.
We were exploring the ability and limitations of Random Forest for identifying the
genetic component of susceptibility and prognosis of bladder cancer in the EPI-
CURO/Spanish Bladder Cancer Study (Garc´ıa-Closas et al., 2005; Guey et al.,
2010), when the Briefings in Bioinformatics journal published the paper Stabil-
ity and aggregation of ranked gene lists by Boulesteix and Slawski (2009), and we
decided to explore the stability of both MDA and MDG rankings in our dataset
using different graphical and numerical descriptive measures proposed in the paper.
The goal of this chapter is to emphasize the importance of exploring ranking stability
when using the importance measures, MDA and MDG, provided by Random Forest.
We show that ranks based on the MDA are unstable to small perturbations of the
dataset and ranks based on the MDG provides more robust results. We illustrate
this with the real data of the Spanish Bladder Cancer Study introduced in Chapter 1
and with a simulated example.
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3.2 The Random Forest methodology
Random Forest performs a bagging (bootstrap aggregation) of tree-based models
(regression and classification trees) and additional modifications that improve its
performance. Bagging is an ensemble technique for reducing the variance of an
estimated prediction function and avoiding overfitting. Random Forest introduces
an additional layer of randomness to bagging by changing the construction of the
tree models. In standard classification and regression trees (CARTs), each node is
split using the best split among all variables and a post-pruning process is made
after tree construction. In Random Forest each tree is fully grown, without pruning,
and at each step of the tree growing process, the best split for each node is chosen
from a random subset of variables. The following scheme describes the Random
Forest algorithm:
• Draw B bootstrap samples from original data.
• For each bootstrap sample grow an unpruned classification or regression tree
Tb by the following steps:
– Select a subsample ofm variables from the whole set of variables available.
– Choose the best split from among the m selected variables.
– Split the node into two nodes.
– For the new nodes, recursively repeat the previous steps until the terminal
nodes containing a single element or a predefined minimum node size is
reached.
• Output the ensemble of the Tb trees, b = 1, . . . , B
The randomForest implementation provides two measures of the importance of
the predictor variables, the mean decrease accuracy (MDA) and mean decrease Gini
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(MDG). MDA quantifies the importance of a variable by measuring the change in
prediction accuracy when the values of the variable are randomly permuted com-
pared to the original observations. MDG is the sum of all decreases in Gini impurity
due to a given variable (when this variable is used to form a split in the Random For-
est), normalized by the number of trees. Most of the papers applying the Random
Forest methodology that we have consulted use the MDA ranking, usually without
any justification of this choice.
3.3 Stability of MDA and MDG rankings
Our data consists of 723 SNPs in the inflammatory pathway, acting as indepen-
dent variables in the Random Forest, and a binary dependent variable indicating
the recurrence of the tumour in the first five years after diagnosis. Our surprise
was the different behaviour in stability displayed by MDA and MDG rankings. In-
deed, while MDG was robust to small perturbations of the data, MDA rankings
behaved completely unstable. In Figure 3.1 and Figure 3.2 we show the scatter-plot
among the original ranking, based on the original dataset, (x-axis) and 100 Jack-
knife rankings (y-axis) where, for each Jackknife sample, 10% of the observations
were randomly selected and removed from the dataset. In Figure 3.1, it is clear that
MDG perturbed and original rankings are correlated and that the stability is more
important in the tail of the original ranking. Instead, in Figure 3.2, one can realize
that, after a small perturbation of the data, any variable, irrespective of its original
MDA ranking, can virtually have any MDA ranking in the perturbed sample.
In addition to the scatter plots, we also explored the average percentage of overlap
in the top-k list between the original rankings and the rankings of the perturbed
datasets as a function of k, for both ranking methods (Figure 3.3). MDG reaches
a stable overlap around 75% for k larger than 25 while MDA maximum coverage is
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Figure 3.1: MDG rank in the original dataset against MDG rank
in the perturbed datasets (10% left out).
around 60% for k approximately equal to 13, but decreasing quickly to only a 50%
as k increases.
Similar results were obtained when we applied the Random Forest algorithm to the
analysis of susceptibility of bladder cancer (the same set of SNPs and a case-control
dependent variable). Again, MDG rankings performed much better in terms of
stability than MDA rankings (data not shown).
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Figure 3.2: MDA rank in the original dataset against MDA rank
in the perturbed datasets (10% left out).
However, as it is also discussed in Boulesteix’s paper, though stability is a neces-
sary property of a good ranking procedure, stability alone does not ensure a good
behaviour of the ranking in the sense that it may not identify the correct variables.
To explore the ability of both ranking measures to capture real known associations,
we performed a small simulation. We simulated a dataset, similar to our bladder
cancer data set, with 1,000 SNPs and a binary dependent variable. Ten SNPs were
associated with the response, following a recessive model with a specified odds-ratio,
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MDG (solid line) and MDA (dashed line)
and the rest were generated at random with different minor allele frequencies.
Table 3.1 and Table 3.2 show, for each of the ten associated SNP, its OR, p-value,
original ranking, and a summary of the perturbed rankings (min, max and quartiles)
for MDG and MDA, respectively. As before, also in this simulated dataset, we
observe much more variability of the MDA ranking than the MDG ranking. Also,
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Table 3.1: MDG ranking results for the 10 associated SNPs.
MDG MDG Jackknife
original rankings summary
SNP OR P-value ranking Min p25 p50 p75 Max
SNP1 3.06 1.06E-05 1 1 1 1 1.25 11
SNP2 2.69 4.25E-05 2 1 2 3 5 25
SNP3 2.54 6.12E-05 3 1 2 3 5 11
SNP4 2.32 0.000115 4 1 3 5 7 29
SNP5 2.16 0.000195 5 1 3 5 8 31
SNP6 1.94 0.000439 6 1 7 10 18 44
SNP7 1.72 0.000570 7 2 4.75 7 10 37
SNP8 1.53 0.001565 15 3 10 14.5 25 90
SNP9 1.31 0.005942 55 9 30 43.5 62.25 263
SNP10 1.22 0.033273 98 17 126.5 223.5 375.8 858
we observe a nice behaviour of the MDG original ranking, capturing the decreasing
association order of the simulated SNPs. Instead, MDA ranking was not able to
capture the order in the association effect.
Finally, Table 3.3 shows, for each SNP, its probability of being in the top-k list, with
k = 10, 20 and 50. MDG picks-up the first 4 SNPS in the top-10 list and the first
7 SNPs in the top-20 list in approximated 90% of cases. MDA is only able to select
SNP1 with this high probability in the top-10 list and the first 3 SNPs in the top-20
list. MDG puts almost always the first 8 SNPs in the top-50 list while MDA only
picks-up the first 4 SNPs in the top-50 list with probability near 1. Neither MDG
nor MDA are able to pick-up SNP9 and SNP10.
In addition to stability problems, there are other aspects that can affect the good
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Table 3.2: MDA ranking results for the 10 associated SNPs.
MDA MDA Jackknife
original rankings summary
SNP OR P-value ranking Min p25 p50 p75 Max
SNP1 3.06 1.06E-05 1 1 1 1 2 26
SNP2 2.69 4.25E-05 5 1 2 5 10 49
SNP3 2.54 6.12E-05 2 1 3 5 10 40
SNP4 2.32 0.000115 16 1 4 8 14 112
SNP5 2.16 0.000195 8 1 7.75 12 22 774
SNP6 1.94 0.000439 3 2 13.75 22.5 62.25 910
SNP7 1.72 0.000570 12 2 10.75 21.5 64 975
SNP8 1.53 0.001565 649 5 28.5 122.5 507.2 988
SNP9 1.31 0.005942 49 11 88.75 270.5 662.5 998
SNP10 1.22 0.033273 738 23 236 445.5 786.8 996
performance of a ranking procedure. Strobl et al. (2007) discuss different aspects,
such as correlation between the predictor variables and the scale or the number of
categories of these predictors, that can induce bias in the Random Forest importance
measures. In absence of these sources of bias, the two specific examples, although
not pretending to be representative of the wide range of possible situations, clearly
illustrate that the stability of rankings is an important issue that should be routinely
explored and that the ranks based on the Mean Decrease Gini provide more robust
results.
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Table 3.3: MDG and MDA rankings. Probabilities of being in the
top-10, -20 or -50 list.
SNP MDG.P10 MDG.P20 MDG.P50 MDA.P10 MDA.P20 MDA.P50
SNP1 0.99 1 1 0.98 0.99 1
SNP2 0.95 0.99 1 0.77 0.94 1
SNP3 0.97 1 1 0.79 0.97 1
SNP4 0.9 0.99 1 0.65 0.83 0.96
SNP5 0.87 0.95 1 0.43 0.72 0.84
SNP6 0.53 0.85 1 0.18 0.42 0.72
SNP7 0.76 0.94 1 0.25 0.49 0.72
SNP8 0.3 0.65 0.96 0.05 0.16 0.37
SNP9 0.01 0.09 0.65 0 0.05 0.17
SNP10 0 0.01 0.06 0 0 0.06
CHAPTER 4
Robust feature selection with Random Forest
In this chapter we propose a new strategy for variable selection using Random
Forest. The proposed algorithm, namely AUC-RF, computes the Receiver Operating
Curve (ROC) associated to the Random Forest, uses the area-under-the ROC curve
(AUC) as the predictive accuracy of the Random Forest and implements a backward
elimination process for selecting the set of variables with the highest AUC value.
The goal of this chapter is two-fold: establish AUC as a preferable accuracy measure
for Random Forests in front of the usual classification error rate and to provide a
new selection algorithm based on the AUC. In particular, we show that the use of
the classification error is especially inappropriate when dealing with unbalanced data
sets. The new AUC-RF procedure for variable selection is illustrated with data from
the Spanish Bladder Cancer/EPICURO Study (described in Chapter 1) and also
with simulated data. The content of this chapter has been published in the Human
Heredity journal (Calle et al., 2011) and the algorithm is publicly available as an
R package, named AUCRF, at http://cran.r-project.org/web/packages/AUCRF
and the package documentation can be found in appendix B.
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4.1 Introduction
Genomic profiling, the use of genetic variants at multiple loci simultaneously for
prediction of disease risk, requires the selection of the set of genetic variants that
best predicts disease status. The goal of this chapter is to provide a new selection
algorithm for genomic profiling.
We propose a new algorithm for genomic profiling based on optimizing the area-
under-the ROC curve (AUC) of the Random Forest. The proposed strategy im-
plements a backward elimination process based on the initial ranking of variables.
We demonstrate the advantage of using the AUC instead of the classification er-
ror as a measure of predictive accuracy of the Random Forest. In particular, we
show that the use of the classification error is especially inappropriate when dealing
with unbalanced datasets. The new procedure for variable selection and prediction,
namely AUC-RF, is illustrated with data from a bladder cancer study and also with
simulated data.
Dı´az-Uriarte and Alvarez de Andre´s (2006) proposed a backward elimination method
for obtaining the optimal subset of variables providing the lowest overall classifica-
tion error, implemented in the R package varSelRF (Diaz-Uriarte, 2007). This
method is based on two default strategies of the Random Forest, the most voted
class for prediction and the out-of-bag classification error rate (OOB-ER) for accu-
racy. As mentioned before, for unbalanced data sets, the most voted class strategy
tends to classify almost all individuals in the largest class and the classification er-
ror rate does not distinguish between false positives (FP) and false negatives (FN)
which can give a false impression of accuracy (for instance, in a data set with 80% of
controls and 20% of cases, a method that correctly classifies all controls but classifies
cases randomly will have a classification error rate of only 10%). We prove that the
proposed new algorithm overcomes these limitations.
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In the context of a genetic study, the AUC-RF algorithm can be used for genomic
profiling, that is, for identifying the set of variants with the highest combined pre-
dictive value of individual risk of disease. Our goal was to use this methodology for
exploring the contribution of the inflammation pathway on bladder carcinogenesis
through the Spanish Bladder Cancer Study data. Stratified analysis by tobacco
smoking risk group was also of interest. While the whole sample was approximately
balanced, the stratified samples were strongly unbalanced and, in this case, the use
of Random Forest for variable selection based on the classification error rate was not
satisfactory. This was the motivation of the new proposed strategy for variable se-
lection using Random Forest. A simulation analysis has been conducted to evaluate
the effectiveness of the AUC-RF method for selecting causative SNPs. Balanced and
unbalanced scenarios have been simulated considering different numbers of causal
SNPs, relative risks, minor allele frequencies (MAF) and disease prevalence. Though
RF can be used for both discrete and continuous dependent variables we will ex-
plain the approach for a binary dependent variable representing disease status in
the context of a case-control association study.
4.2 Methods
4.2.1 AUC-RF for feature selection
The AUC-RF algorithm iteratively fits Random Forests and eliminates a proportion
of variables. Denote by D = (Y ;X) the n × (k + 1) matrix corresponding to the
data set of interest where n is the number of individuals, Y is the binary dependent
variable and X = (X1, . . . , Xk) is the n×k matrix containing the predictor variables.
The AUC-RF algorithm is described below:
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1. Iterative process:
First step:
• Denote by X1 the initial set of predictor variables (X1 = X) and by
D1 = (Y ; X1) = D the initial data set.
• Build a Random Forest RF 1 on D1, that is, using all predictor variables
and the response (see subsection Random Forest parameters below)
• Obtain the ranking of the predictor variables using the chosen measure
of importance (see subsection Random Forest importance measures for
details). Denote by r = (r1, . . . , rk) the ranking vector of variables
(X1, . . . , Xk).
• Compute the out-of-bag AUC (OOB-AUC) of the Random Forest RF 1,
namely OOB-AUC1 (see subsection Random Forest prediction and AUC
computation for details).
Subsequent steps. Step j, j > 1:
• Based on the initial ranking r, remove a fraction (by default 20%) of the
less important variables from Xj−1 and denote the resulting matrix of
predictors as Xj.
• Denote by Dj the reduced data set: Dj = (Y ; Xj)
• Build a Random Forest on Dj, namely RF j.
• Compute the OOB-AUC of the Random ForestRF j , namely OOB-AUCj.
Repeat step j until
• the number of remaining variables is less than k0 (by default k0 = 1).
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2. Elimination process representation:
The elimination process is visualized with a curve describing the OOB-AUC
value, OOB-AUCj, of Random Forest RF j (y − axis) as a function of the
number of predictor variables (x− axis).
3. Optimal set of predictors:
The optimal set of predictor variables is the one giving rise to the Random
Forest with the highest OOB-AUC, denoted by OOB-AUCopt. The number of
selected predictors is denoted by Kopt.
4. Predictive accuracy and probability of selection:
The obtained OOB-AUCopt value cannot be considered as the genuine pre-
dictive accuracy of the selected variables on a new data set. It is inflated by
the fact that it is measured on the same training data set that has been used
for the selection process. A correction of this overoptimism is required. Also
of special concern is the robustness of the rankings and, consequently, of the
selected variables (Boulesteix and Slawski, 2009). AUC-RF deals with these
two important issues by performing a repeated cross-validation analysis. The
results of this analysis provide a corrected estimation of the predictive accu-
racy of the selected variables and an estimate of the probability of selection for
each variable (Pepe et al., 2003). For ease of notation we illustrate this process
in the case of a 5-fold-cross-validation process that is repeated 20 times.
• For m = 1, . . . ,M = 20 repeat a 5-fold-cv process consisting of the
following steps:
(a) Divide the original data set into 5 subsets: Dm1 , . . . , D
m
5 ,
(b) For j = 1, . . . , J = 5
– Perform the AUC-RF feature selection on the learning data set,
Lm,j = D −Dm,j.
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– Let RFm,jopt denote the optimal Random Forest (after feature elim-
ination) and Sm,jopt the set of selected variables.
– Use RFm,jopt to predict individuals in the test data set D
m,j (See
Subsection Random Forest prediction and AUC computation).
This provides a vector of probabilities, Predm,j , corresponding
to the proportion of trees yielding Y = 1.
(c) Join the predictions of the 5 cv subsets, (Predm,1, . . . , P redm,5), and
compute the AUC of these predictions, denoted by cv-AUCm.
• Compute the mean cv-AUC = 1
M
∑M=20
m=1 cv-AUC
m .
• For each variable Xi, i = 1, . . . , k, we compute its probability of selection
as the proportion of times that it has been selected by the AUC-RF
method:
P (Xi) =
1
M ∗ J
j=5∑
j=1
m=1∑
M=20
1(Xi ∈ Sm,jopt )
4.2.2 Random Forest parameters
AUC-RF uses Random Forest with the default parameters of the R-package ran-
domForest available at http://cran.r-project.org/web/packages/randomForest.
The most relevant specifications are ntree=500 (the number of trees in a for-
est is 500), mtry=
√
n (the number of selected candidate variables in each node
is the squared of the total number of variables) and replace=TRUE, nodesize=1,
maxnodes=NULL, importance=FALSE, norm.votes=TRUE (see the randomForest
documentation for details). These default values can be modified when randomFor-
est function is called.
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4.2.3 Random Forest importance measures
Random Forest, as implemented in the R-package randomForest, provides two dif-
ferent importance measures, mean decrease accuracy (MDA) and mean decrease
Gini (MDG). MDA quantifies the importance of a variable by measuring the change
in prediction accuracy when the values of the variable are randomly permuted com-
pared to the original observations. MDG is the sum of all decreases in Gini impurity
due to a given variable (when this variable is used to form a split in the Random
Forest), normalized by the number of trees. Strobl et al. (Strobl et al., 2008, 2007)
studied different mechanisms that can induce bias in the Random Forest importance
measures and Calle et al. (Calle et al., 2010) explored stability of these measures,
as described in chapter 3. On the one hand, both the MDG and MDA importance
measures may be biased in the case of variables with different scales or in the case
of categorical variables with different numbers of categories (Strobl et al., 2007),
but in the context of SNP data analysis (almost) all variables are three-categorical.
On the other hand, in terms of robustness, the ranks based on the MDA provide
very unstable results (Calle et al., 2010). More research is needed to elucidate the
respective advantages and inconveniences of MDG and MDA in general. However,
in the considered context, our preliminary study has clearly shown that MDA per-
forms consistently and substantially worse than MDG, probably because of its high
instability. We will thus use MDG it in this chapter for both the bladder cancer
analysis and the simulation study.
4.2.4 Random Forest prediction and AUC computation
The individual class prediction using Random Forest is based on what are called
the votes. The principle is that each tree votes for a class and that the predicted
class of an individual is finally the class with more votes. However, the voting
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procedure differs depending whether one wants to compute the so-called Out-Of-
Bag Error Rate (OOB-ER) or rather make predictions for new individuals from a
test data set. If the goal is to compute the OOB-ER, those trees for which an
individual was out-of-bag (i.e. was not used to build the tree) contribute with a
vote to the predictive class for this individual. For dichotomous class prediction
(Y = 0, Y = 1), the votes are two variables (v0, v1), where v0 is the number of
votes for class Y = 0 and v1 is the number of votes for class Y = 1. The total
number v0 + v1 is the number of trees for which the individual was out-of-bag:
approximately a third of the total number of trees when replace=TRUE is used.
The OOB-ER is then defined as the proportion of individuals with predicted class
different from the true class. If the goal is to predict new individuals from a test
data set the procedure is similar but in this case all trees in the RF contribute
with a vote (v0 + v1 = ntree), since the individual was never used to build the
trees. The default prediction procedure is to predict the most voted class and to
provide the OOB-ER. Alternatively, AUC-RF explores the predictive accuracy of
the Random Forest through its ROC curve and the corresponding AUC (area under
the ROC curve) (Pepe, 2003). The AUC-RF procedure computes the AUC based
on out-of-bag predictions, similarly to the OOB-ER, hence the notation OOB-AUC.
Each individual is characterized by the numbers v0 or v1 of trees predicting Y = 0
and Y = 1, respectively. The ROC curve plots sensitivity against 1-specificity and
can be obtained by varying the cutoff, c, in the prediction procedure based on the
votes. The randomForest package allows to specify the cutoff as a vector (1− c, c)
and then predicts an individual as Yˆ = 1 if v0 · c < v1 · (1 − c) . The most voted
class strategy corresponds to c = 0.5. The OOB-AUC can be calculated directly
from the mean rank of the cases, denoted by r1, as AUC =
1
n0
(r1− n12 − 12) where n1
and n0 are the number of cases and controls, respectively, and the ranks are based
on the proportion of trees yielding Y = 1, that is, v1/(v0 + v1) (Wray et al., 2010).
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4.3 Application
4.3.1 The Spanish Bladder Cancer/EPICURO Study
Here we center our attention on the analysis of the joint effect of multiple genes in
the inflammation pathway on bladder carcinogenesis for which information on 282
SNPs genotyped in a total of 108 genes in this pathway is available. After excluding
patients with more than 20% missing genotypes, the available sample for analysis
consists of 1150 cases and 1149 controls. The remaining missing genotypes were
imputed using function rfimpute provided in randomForest library. Smoking is
the most important risk factor for bladder cancer and gene×smoking interactions
has been reported (Garc´ıa-Closas et al., 2005; Samanic et al., 2006). For this reason,
we were interested in performing a stratified analysis by tobacco smoking risk group
(current smokers, former smokers and never smokers).
We use the never smokers group, an unbalanced data set consisting of 426 con-
trols and 209 cases, for illustration of the proposed methodology, AUC-RF, and
for comparison with varSelRF by Diaz-Uriarte. The backward elimination process
performed by varSelRF algorithm is depicted in Figure 4.1. As it was anticipated,
the use of the most voted classification strategy and the OOB-ER provides unsat-
isfactory results in the unbalanced non-smokers data set. The first RF, considering
all variables, results in an OOB-ER = 0.32. Though, in some contexts, a predictive
error of 32% could be acceptable, in this case, this value only reflects the proportion
of cases in the sample, which are almost all incorrectly classified as controls. Indeed,
all 426 controls are predicted as controls (classification error = 0) but only 12 out
of the total 209 cases are classified as cases (classification error =0.94). A simi-
lar behaviour is observed for the subsequent RF built in the backward elimination
process, providing always an OOB-ER around 0.3 and, consequently, an OOB-ER
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curve almost flat which is not useful for identifying the optimal subset of predictors.
In this case, varSelRF feature selection algorithm selects only 3 variables providing
an OOB-ER = 0.31.
llllllllll
l
lll
lllllll
l
2 5 10 20 50 100 200
0.0
0.1
0.2
0.3
0.4
0.5
Number of variables used
O
O
B 
er
ro
r
Figure 4.1: varSelRF backward elimination procedure.
The backward elimination process performed by the AUC-RF algorithm using the
MDG importance measure can be visualized in Figure 4.2. The points in the curve
correspond to the OOB-AUC of consecutive RF obtained with the remaining vari-
ables, after the less important variables were removed. The plot is built from the
right (all variables) to the left (one variable). The optimal OOB-AUC is provided
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by the top 43 more important variables, giving an OOB-AUCopt equal to 0.721.
Correction for overfitting was performed with a 5-cv analysis and a cv-AUC = 0.56
was obtained.
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Figure 4.2: AUC-RF backward elimination procedure.
An important concern of selection methods, especially when they are based on rank-
ings, is the robustness of the rankings and, consequently, of the selected set of SNPs.
It is possible that different sets of variables provide practically the same predictive
accuracy. For this reason, it is very important to provide the list of selected variables
together with a measure of robustness of this selection. The AUC-RF algorithm im-
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plements a repeated cross-validation process that provides the percentage of times
that each variable has been selected. In this data set we repeated 20 times a 5-fold
cv process. Table 4.1 provides the list of the most important SNPs that were se-
lected by AUC-RF at least 70% of the times. We can see that the selection of this
set of 18 SNPs is very robust, with the top two being selected almost every time.
Table 4.1: SCBS. Most important SNPs, MDG index
and probability of selection (P).
NCBI gene reference
sequence (SNP Id) MDG P
abca1.04 3.7387 1
masp1.53 2.6158 0.99
ephx2.04 2.6030 0.96
il10.17 2.1866 0.89
lta.04 2.0868 0.89
fcgr2a.01 2.3368 0.88
ptgs2.05 2.0644 0.85
ccr2.02 1.8030 0.80
csf1r.05 2.0657 0.79
mbl2.12 1.9348 0.78
gdf15.02 1.8225 0.77
alox5.10 1.6049 0.77
tlr2.04 1.7858 0.74
il4r.10 1.6247 0.74
cd86.02 1.6072 0.71
alox5.28 1.7345 0.70
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4.3.2 Alzheimer’s disease Study
The Alzheimer’s disease study was introduced in chapter 1. A total of 682 SNPs in
32 genes of the reelin pathway are analyzed on a total of 1411 individuals (861 cases
and 550 controls). Figures 4.3 to 4.5 show the AUC-RF output for the Alzheimer’s
disease data set including all the individuals and stratifying by APOE-4 carriers
and noncarriers. For the case with no stratification, the optimal OOB-AUC is pro-
vided by the top 43 more important variables, giving an OOB-AUCopt equal to
0.629. For APOE-4 carriers strata, we obtain 34 variables and a value of 0.703 for
OOB-AUCopt, and also 34 variables and OOB-AUCopt = 0.6528 for APOE-4 non-
carriers strata. However, when cross-validation analysis is performed the obtained
cv-AUC values are close to 0.5 in the three cases which means that the SNPs have
no predictive capacity on AD status.
4.3.3 Simulation Study
We performed a simulation study with the goal of investigating the performance
of the proposed AUC-RF method for selecting variables with predictive capacity.
We generated a set of k causal SNPs and 1000 − k non-causal SNPs. We fol-
lowed the strategy described in chapter 3 for simulating the causal SNPs assuming
independence and a multiplicative odds of risk model. All causal SNPs were as-
sumed to be in HWE, to have the same effect size on the response and the same
genotype frequencies. For each causal SNP we fixed the heterozygous relative risk
(RR1) and assumed that the minor homozygous relative risk is RR2 = (RR1)2.
We investigated the role of disease prevalence (p = 0.01, 0.1, 0.2, 0.3), effect size
(RR1 = 1.1, 1.3, 1.5), Minor Allele Frequencies (MAF = 0.1, 0.2, 0.3) on bal-
anced (N0 = number of controls = N1 = number of cases = 2000) and unbalanced
(N0 = 3000 and N1 = 1000) data sets. The number of causal SNPs was k = 10, 50
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Figure 4.3: AUC-RF backward elimination procedure for AD data set.
and, for RR1 = 1.1, we further explored k = 100. This yield a total of 192 scenarios.
For each scenario we generated two data sets, a learning data set (LD) and a test
data set (TD) that was used for validation of the predictive accuracy of the selected
set of SNPs. We performed the AUC-RF feature selection algorithm and kept the
percentage (Pc) of causal SNPs that AUC-RF picks-up and the predictive accuracy
of the selected set of SNPs on the test data set, denoted by test-AUC. This predic-
tive accuracy depends on the ability of the algorithm to identify the causal SNPs
but also on the predictive capacity of the causal SNPs. Thus, we also computed the
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Figure 4.4: AUC-RF backward elimination procedure for
ApoE-4 carriers in AD data set.
predictive ability of the causal SNPs as follows: Each individual is assigned a risk
score given by
k∑
j=1
(1{Gj = 1} · logOR1j + 1{Gj = 2} · logOR2j)
where OR1 is the odds-ratio of heterozygous vs major homozygous and OR2 is the
odds-ratio of minor homozygous vs major homozygous. We computed the AUC of
predictions based on the above risk score, denoted by score-AUC. The score-AUC
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Figure 4.5: AUC-RF backward elimination procedure for
ApoE-4 noncarriers AD data set.
can be seen as the best empirical predictive accuracy provided by the causal SNPs,
if they were known, and will be used as a reference for interpreting the observed
predictive accuracy of the AUC-RF method. We repeated this process 100 times for
each scenario and averaged the results over the 100 replications.
We summarize the results of the simulation study in terms of the percentage of
selected causal SNPs, denoted by Pc, in Tables 4.2 to 4.4 . The predictive accuracy
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of the selected set of SNPs on the test data set, denoted test-AUC, is reported in
Tables 4.5 to 4.7 . The score-AUC is also provided in parenthesis as a reference
value of the maximum predictive accuracy of the causal SNPs. In order to visualize
some of the obtained results, Figures 4.6 and 4.7 show the results for k = 50 and
balanced data set. The percentage, Pc, of causal SNPs that AUC-RF is able to
pick-up is mainly affected by the effect size, followed by the minor allele frequency
and the disease prevalence (Figure 4.6 and Tables 4.2 to 4.4). For RR1 = 1.5,
the percentage Pc is almost 100% in all cases, that is, all causal SNPs are identi-
fied. When RR1 reduces to 1.3 the efficacy remains for MAF = 0.3 and 0.2 but
reduces considerably for MAF = 0.1. For RR1 = 1.1 the percentage of selected
causal SNPs reduces drastically to 30-40% for MAF = 0.3, 10-20% for MAF = 0.2
and it is almost null for MAF = 0.1. A slight effect of the disease prevalence is
observed in some situations: For RR1 = 1.3 and MAF = 0.1 and RR1 = 1.1
and MAF = 0.3, 0.2; the largest the prevalence, the higher the percentage Pc. A
similar behaviour is observed in terms of predictive accuracy of the set of selected
SNPs (Figure 4.7 and Tables 4.5 to 4.7). For RR1 = 1.5, the test-AUC is very
high (around 0.8-0.9) which corresponds to very accurate predictions. Indeed, the
obtained test-AUC after feature selection is very similar to the score-AUC provided
by all causal SNPs (given in parenthesis). The effect of the genotype frequencies is
observed, with MAF = 0.3 giving slightly better results than for MAF = 0.2 and
better than for MAF = 0.1. Instead, the disease prevalence effect is not apparent
in terms of test-AUC. For RR1 = 1.3 the predictive accuracy is around 0.7-0.8 when
MAF = 0.2, 0.3 and around 0.65 when MAF = 0.1. The loss in predictive capacity
(comparing the obtained test-AUC with the score-AUC) is more apparent for low
values of MAF (around 7% when MAF = 0.1). In this case, the effect of disease
prevalence is not apparent. For RR1 = 1.1 the predictive capacity of the selected set
of SNPs is in general very low or non-existent. Note, however, that in this setting
the score-AUC given by all causal SNPs is also very low. Only for k = 100 and
MAF = 0.3 we obtain more acceptable predictive values, around 0.6. This is in
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accordance with Janssens et al. (2007) who say that a genomic profile from a set
of causal SNPs with such a weak marginal effect on the phenotype will require a
larger number of SNPs to jointly get a useful predictive accuracy. Indeed, we can
observe looking at Tables 4.5 to 4.7 that the larger the number k of causal SNPs
the larger the AUC (both score-AUC and test-AUC) in all settings. Instead, this
effect of the number of causal SNPs is not observed in the efficacy of the AUC-RF
method for detecting causal SNPs (Tables 4.2 to 4.4). For instance, in Tables 4.5
when MAF = 0.1, the percentages Pc of identified causal SNPs are larger for k = 10
than for k = 50.
Table 4.2: Percentage of selected causal SNPs (Pc) for RR1 = 1.5.
Balanced data set Unbalanced data set
Prevalence (p) 0.01 0.1 0.2 0.3 0.01 0.1 0.2 0.3
K=10
MAF=0.1 99.1 99.6 99.9 100 99.4 99.8 99.8 100
MAF=0.2 100 100 100 100 100 100 100 100
MAF=0.3 100 100 100 100 100 100 100 100
K=50
MAF=0.1 96.8 94.3 94.3 94.9 98.1 96.1 96.3 97
MAF=0.2 100 99.8 99.4 99.3 100 99.7 99.5 99.3
MAF=0.3 100 100 99.9 99.8 100 99.9 99.7 99.7
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Table 4.3: Percentage of selected causal SNPs (Pc) for RR1 = 1.3.
Balanced data set Unbalanced data set
Prevalence (p) 0.01 0.1 0.2 0.3 0.01 0.1 0.2 0.3
K=10
MAF=0.1 62.6 72 83.8 93.4 74.9 81.4 90.6 96
MAF=0.2 96.8 98.5 99.9 99.9 98 98.4 99.6 99.9
MAF=0.3 99.9 100 100 100 99.5 99.9 100 100
K=50
MAF=0.1 57.3 59.2 64.9 72.1 71.7 72.4 76 83.3
MAF=0.2 94.2 92.9 92.7 94.3 96.5 94.8 94.8 96.5
MAF=0.3 99.3 98.6 98.3 98.3 98.9 97.5 97.7 98.2
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Table 4.4: Percentage of selected causal SNPs (Pc) for RR1 = 1.1.
Balanced data set Unbalanced data set
Prevalence (p) 0.01 0.1 0.2 0.3 0.01 0.1 0.2 0.3
K=10
MAF=0.1 1.9 2.4 4.1 5.8 9.6 11.6 13.8 16.3
MAF=0.2 14.8 18.8 21.8 27.7 31.5 31.6 40.4 50
MAF=0.3 36.8 43.8 50.9 61.7 44.7 51.6 58.3 67.2
K=50
MAF=0.1 2.2 2.4 3.6 5 9.8 11.1 13 17
MAF=0.2 13.4 16.3 20.2 27.3 30 34.1 37.7 45.3
MAF=0.3 34.5 39.7 45.1 53.4 44 46.8 53.7 60.6
K=100
MAF=0.1 2 2.5 3.2 4.4 9.3 10.1 13.1 15.7
MAF=0.2 13.6 15.5 18.5 22.4 29.3 31.9 36.5 40.7
MAF=0.3 33.7 36.2 40.5 47 44.5 46.4 50.4 54.8
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Figure 4.6: Proportion of selected causal SNPs for k = 50 and balanced data sets.
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Figure 4.7: AUC of the selected SNPs for k = 50 and balanced data sets.
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4.4 Discussion
In this work we proposed a new feature selection strategy consisting of a backward
elimination process for optimization of the Random Forest AUC. The application
of this method to a real bladder cancer study proves that the default RF most
voted class prediction strategy together with the use of the classification error rate
provides unsatisfactory results in unbalanced data sets. However, even for balanced
data sets, the use of the AUC is preferable to the classification error rate because the
error rate is dependent on the case/control rates in the sample which not necessarily
represent the case/control rates in the population. The use of the AUC is especially
appealing after the recent increasing interest on this measure in the molecular and
genetic epidemiology field (Jakobsdottir et al., 2009; Janssens et al., 2006; Kraft
et al., 2009; Lu and Elston, 2008; Lu et al., 2010; Moonesinghe et al., 2010; Pepe
et al., 2004; Wray et al., 2010). The maximum value of the AUC of a genetic risk
predictor model has been related to the heritability and prevalence of the disease.
In the proposed approach the same initial ranking is used for all iterations in the
backward elimination process. Jiang et al. proposed a backward elimination strategy
for variable selection using RF similar to Diaz Uriarte’s method, the main difference
being the recomputation of the ranking of the remaining variables at each step of
the elimination process (Jiang et al., 2004). In our opinion a potential drawback of
this strategy is that it might accentuate the overfitting problem already present in
any elimination process, giving rise to an increase of overfitting.
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CHAPTER 5
Identification of high-order genetic interactions
using the likelihood-ratio score
In this chapter we consider the use of the likelihood ratio score for exploring high-
order interactions. We propose a forward selection method for obtaining sets of
genetic variants (SNPs) with optimal prediction accuracy. The proposed algorithm,
namely Optimal AUC, is computationally feasible for exploring higher order inter-
actions, not only second or third order interactions, in a large number of variables
setting. The new procedure for epistasis identification is illustrated with data from
the Alzheimer Disease Association Study (described in Chapter 1) and also with
simulated data.
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5.1 Introduction
Many statistical methods for epistasis analysis have been proposed, from exhaustive
searches using regression models including interactions (Marchini et al., 2005) to
data-mining methods such as the Model-Based Multifactor Dimensionality Reduc-
tion method (Calle et al., 2010) that is an extension of the popular MDR method
(Ritchie et al., 2003) but allows adjusting for marginal effects and confounders. An
overview on this topic is given by Van Steen (2012). These methods are usually
able to scan for second order interactions but, since they are very computationally
demanding, they become infeasible for exploring higher order interactions when the
number of variables to explore is large, as it is usually the case.
In this chapter we propose a new strategy for exploring the joint predictive effect
of a set of genetic or environmental factors, including their possible interactions.
The proposed method, referred to as the ”Optimal AUC algorithm”, is based on
the likelihood ratio score. Given a set of predictors, the likelihood ratio score pro-
vides an optimal prediction of a binary variable in the sense that it provides the
largest discrimination accuracy among all possible risk scores derived from the set
of predictors (McIntosh and Pepe, 2002).
The Optimal AUC algorithm follows a process of forward selection to obtain the
subset of factors with the highest joint predictive accuracy. The algorithm is com-
putationally feasible for exploring higher order interactions, not only second or third
order interactions, in a large number of variables context.
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5.2 Optimal prediction and optimal ROC curve
In this section we address the question of how to combine multiple predictors to
obtain the best possible prediction of disease risk. We focus in case-control genetic
association studies where the outcome of interest is a binary variable Y that informs
of the presence (Y = 1) or absence (Y = 0) of a disease and the predictors are
G = (G1, . . . , Gm), a set of m genetic markers that have been genotyped on each
subject. We assume that the genetic markers are single-nucleotide polymorphisms
(SNP). The observed data is of the form (Y i, Gi1, . . . , G
i
m), i = 1, . . . , n, where n is
the number of individuals, Y i is disease status for individual i and Gik is the genotype
(0, 1 or 2) of individual i for marker k.
Our goal is to predict P (Y i = 1 | Gi1, . . . , Gim), the probability of being diseased
based on the genetic profiles of each individual. A relevant question is how to
choose the best combination of genetic markers in order to optimize the prediction
accuracy. There are several measures of prediction accuracy that can be used. Here
we focus on the area under the receiver operating characteristic curve (ROC curve),
that is denoted by AUC.
The prediction of a dichotomous variable given a set of variables is usually based
on what is known as the risk score. In our setting, the risk score given the genetic
markers is a real valued function S = S(G1, . . . , Gm) so that larger values of S are
associated to higher disease risk. Predictions based on S are of the form:
Yˆ i =
 1 if Si ≥ c0 if Si < c
where c is a threshold parameter.
For every possible value of c we can define the true positive rate TP (c) as the
probability of a diseased individual to be correctly predicted as diseased, TP (c) =
72 Chapter 5. Identification of high-order genetic interactions using LR score
P (S > c | Y = 1), and the false positive rate FP (c) as the probability of a non
diseased individuals to be incorrectly predicted as diseased, FP (c) = P (S > c | Y =
0). The ROC curve is used for exploring the prediction accuracy of a score function S
for the different possible cut-offs. It consists of a plot of the true positive rate (y axis)
against the false positive rate (x axis), or, equivalently, sensitivity vs (1−specificity).
More formally, the ROC curve is defined as the set of points {(FP (c), TP (c)), c ∈
(−∞,∞)}. The ROC curve is a monotone increasing function from (0, 0) to (1, 1).
A risk score S with a ROC curve that is closer to (0, 1) represents a very accurate
prediction model.
The area under the ROC curve (AUC) provides a measure of discrimination of
the risk score among diseased and non-diseased individuals. AUC takes values in
the range (0.5, 1), where 1 represents perfect discrimination for some threshold c
while 0.5 indicates that the risk score S has no discrimination capacity. It can be
shown that the AUC is equal to the probability that a diseased individual has a
score larger than a non-diseased: AUC = P [S(Y = 1) > S(Y = 0)]. In Figure 5.1
two ROC curves have been plotted. The black curve has an AUC of 0.9293 that
describes an almost perfect discrimination. The grey curve has an AUC of 0.6899
corresponding to a moderate capacity of discrimination.
The logistic regression model, defined as a linear model for the log-odds of disease,
is the most popular method for combining multiple predictors when the output is a
binary variable:
log (P (Y = 1)/ (1− P (Y = 1))) = β0 + β1G1 + · · ·+ βmGm .
In this model the risk score is the linear part of the model S = β0+β1G1+· · ·+βmGm.
However, the logistic regression is not necessarily the best predictive model. Pepe
(2003) proved that the optimal risk score for predicting a binary variable Y given
G = (G1, . . . , Gm) is the likelihood ratio score:
LR(G) = LR(G1, . . . , Gm) =
P (G1, . . . , Gm | Y = 1)
P (G1, . . . , Gm | Y = 0) .
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Figure 5.1: Example of ROC curves.
Proposition 1. The likelihood ratio score is the best test for discrimination between
cases and controls based on (G1, . . . , Gm). The ROC curve for LR(G) is uniformly
above any other ROC curves based on (G1, . . . , Gm). Thus, AUCLR ≥ AUCS for
any risk score S based on (G1, . . . , Gm). The ROC curve for the likelihood ratio
score, LR(G), receives the name of optimal ROC curve and AUCopt{G1, . . . , Gm}
denotes the AUC of the optimal ROC curve and is referred to as the optimal AUC.
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Graphical proof
Let’s sketch a graphical proof of the above result, that the ROC curve of the like-
lihood ratio score of a set of variables is always above any other ROC curve based
on the same variables.
In our case, where the predictors are categorical variables with three categories, a
risk score S based on G = (G1, . . . , Gm) is a discrete function with K = 3
m different
categories corresponding to the total number of different multilocus genotypes. We
denote by Gk (with an upper index) for k = 1, . . . , K = 3m the different possible
realizations of G. The ROC curve is then obtained by ranking the multilocus geno-
types according to S in decreasing order, S(G(1)) ≥ S(G(2)) ≥ · · · ≥ S(G(K)), where
G(k) denotes the multilocus genotype with rank k for k = 1, . . . , K = 3m, and then
by computing the true positive and false positive rates. For a threshold c such that
S(G(k)) ≥ c ≥ S(G(k+1)) and k = 1, . . . , K = 3m:
 TP (c) = P (S > c | Y = 1) =
∑k
j=1 P (G
(j) | Y = 1)
FP (c) = P (S > c | Y = 0) = ∑kj=1 P (G(j) | Y = 0)
Graphically this means that the ROC curve is built by adding consecutive triangles
with basis P (G(j) | Y = 0) and height P (G(j) | Y = 1) for j = 1, . . . , K = 3m.
The slope of the j-th triangle is P (G(j) | Y = 1)/P (G(j) | Y = 0) which is equal to
LR(G(j)), the likelihood ratio of G(j). When we use the likelihood ratio score,
the multilocus genotypes are ranked according to a decreasing likelihood ratio:
LR(G(1)) ≥ LR(G(2)) ≥ · · · ≥ LR(G(K)). Thus, when we built the ROC curve
of LR we start with the triangle with the largest slope, then the second triangle
with the second largest slope and so on, yielding a concave curve that is always
above any other possible ROC curve based on G.
5.2. Optimal prediction and optimal ROC curve 75
Example with two genetic markers
Two genetic markers (SNPs), G1 and G2, define a partition of the sample space
into 9 categories, Gj, j = 1, . . . , 9. The likelihood ratio for each category j can be
estimated as the proportion of cases divided by the proportion of controls in the
category:
LˆR(Gj) =
(
∑n
i=1 1 {(Gi1, Gi2) = Gj, Y i = 1}) /n1
(
∑n
i=1 1 {(Gi1, Gi2) = Gj, Y i = 0}) /n0
where n1 =
∑n
i=1 1 {Y i = 1} is the number of cases and n0 =
∑n
i=1 1 {Y i = 0} is the
number of controls. The different categories are ordered according to the likelihood
ratio score and the ROC curve is obtained as described before.
To illustrate these concepts we consider a simulated case-control study with 1600
subjects (800 cases and 800 controls) and 1000 SNPs. The first two SNPs (SNP1
and SNP2) in this dataset are associated with the case-control variables through an
interaction effect but without exhibiting marginal main effects. The remainder 998
variables are not associated with the phenotype. The dataset was downloaded from
”Jason Moore Computational Genetics lab” at http://discovery.dartmouth.edu/
epistatic data. We will also use this dataset in the next section to illustrate the
proposed ”Optimal AUC algorithm”.
Table 5.1 provides a summary of the first two SNPs. The first five columns of the
table show each genotype category combination for the two SNPs, the number of
cases and controls and their proportions in each category, the LR (cases and controls
proportions ratio) for each category and their ranking based on the LR. The AUC
calculated for the ROC curve based on LR is 0.865. For illustrative purposes, we also
fitted a logistic lineal model with the two SNPs as predictors and their associated
ROC curve. As expected, no significant terms were detected and the corresponding
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ROC curve based on the regression model has an AUC of 0.49. Finally we also fit-
ted the logistic regression model including the interaction terms for the two SNPs.
In this case we obtained a significant model with the same ROC curve and AUC
obtained for the model based on the LR. The three ROC curves are represented in
Figure 5.2.
Table 5.1: Optimal ROC partition example with two genetic markers.
Proportions LR Ranking
Genotype Cases Controls cases (p1) controls (p0) (p1/p0) LR
G1 = (0, 0) 13 184 0.02 0.23 0.07 9
G2 = (0, 1) 197 82 0.25 0.10 2.40 4
G3 = (0, 2) 67 12 0.08 0.01 5.58 3
G4 = (1, 0) 261 25 0.33 0.03 10.44 1
G5 = (1, 1) 84 284 0.10 0.35 0.30 6
G6 = (1, 2) 52 83 0.06 0.10 0.63 5
G7 = (2, 0) 13 75 0.02 0.09 0.17 7
G8 = (2, 1) 109 16 0.14 0.02 6.81 2
G9 = (2, 2) 4 39 0.00 0.05 0.10 8
Total 800 800
In this example the LR score is clearly better than the logistic regression model
without interaction. However, there is no advantage of using the LR score over
the logistic regression including an interaction since both models provide the same
discrimination accuracy. This is the case not only in this example, in general, the
LR score and the logistic regression with an interaction will provide the same clas-
sification. The advantage of using the LR score over the logistic regression will be
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manifest when dealing with higher-order interactions. In logistic regression the inter-
actions are specified parametrically. A second order interaction is specified through
an additional parameter corresponding to the product of the two interacting vari-
ables. Third order interactions could also be specified parametrically in a logistic
regression model, but this is not feasible for higher order interactions.
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Figure 5.2: Optimal ROC curve and ROC curves based on logistic
regression for data in Table(5.1).
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5.3 Searching for higher-order interactions:
Optimal AUC algorithm
In this section we propose a method, the Optimal AUC algorithm, that uses the
likelihood ratio score and the optimal ROC curve for the identification of subsets of
variables that best predicts disease risk.
Given a set of p genetic markers (SNPs), G1, . . . , Gp, our goal is to identify the
subset of predictors with the highest discrimination accuracy between diseased and
controls. We set m ≤ p, the maximum size of the subsets to be explored.
The proposed algorithm follows a forward selection process where variables are suc-
cessively included in the model according to a prespecified optimization criteria,
that in this case is maximization of the optimal AUC (the AUC of the optimal
ROC curve). Typically, forward selection algorithms start with no variable in the
model and, in the first step, all variables are checked and the one that optimizes the
selection criteria is selected as the first variable in the model. With this strategy
the final model is strongly influenced by the selection of the first variable. This is
not very convenient in contexts like ours where the SNPs have very small marginal
effects. In order to reduce the influence of the first selected variable, we propose to
perform p different forward selection processes, one for each variable G1, . . . , Gp as
the first variable in the model. At the end, we analyze the p resulting models and
select the best one.
The Optimal AUC algorithm consists of the following steps that are briefly described
here. Each step is explained in more detail in the following subsections:
5.3. Searching for higher-order interactions:
Optimal AUC algorithm 79
Optimal AUC algorithm
Step 1: Forward selection process
Given the first SNP, G(1), we select the second SNP, G(2), so that
AUCopt{G(1), G(2)} = max{j=1,...,p}AUCopt{G(1), Gj} .
Given a set of SNPs G(1), . . . , G(k−1), we select G(k) so that
AUCopt{G(1), . . . , G(k−1), G(k)} = max{j=1,...,p}AUCopt{G(1), . . . , G(k−1), Gj}
for k = 2, . . . ,m where m is a fixed value (by default m = 10).
We repeat this process p times, taking each available SNP as the first variable in
the forward selection process: G(1) = Gl for l = 1, . . . , p.
We obtain p models of the form M l = {Gl(1) = Gl, Gl(2), . . . , Gl(m)}, l = 1, . . . , p.
Step 2: Selection of the best model and inference
In this step we select the best among the p models M l, l = 1, . . . , p, that we denote
by M∗ = {G∗(1), G∗(2), . . . , G∗(m)}, and explore its significance.
Step 3: Pruning
Since the size m of the models has been taken arbitrarily, the best model M∗ =
{G∗(1), G∗(2), . . . , G∗(m)}, may contain variables that are not really associated with the
response variable Y and should be removed from the model. This step performs a
pruning process where the last variables in the model are eliminated if they do not
add significant prediction accuracy to the whole model.
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Ye et al. (2011) proposed a forward selection method, called ”forward ROC method”,
for identification of predictive genetic profiles on high-dimensional data including
interactions. Both methods, the ”forward ROC method” and the ”Optimal AUC”
proposed here were developed independently but essentially follow the same strategy:
a forward selection process that maximizes the area under the optimal ROC curve.
However, the implementation of both algorithms is very different and, consequently,
both methods can yield to different models and conclusions. The main differences, as
will be discussed next in more detail, are: the computation of the empirical optimal
AUC, the missing data treatment, the selection of the best m dimensional model
and the pruning process.
5.3.1 Forward selection process
As explained before, the forward selection process performs iteratively the following
variable selection:
Given a set of SNPs G(1), . . . , G(k−1), we select G(k) so that
AUCopt{G(1), . . . , G(k−1), G(k)} = max{j=1,...,p}AUCopt{G(1), . . . , G(k−1), Gj}
for k = 2, . . . ,m
This process requires the computation of the optimal AUC that is defined as the area
under the optimal ROC curve. The optimal ROC curve for k variables G1, . . . , Gk
is given by the likelihood ratio score:
LR(G1, . . . , Gk) =
P (G1, . . . , Gk | Y = 1)
P (G1, . . . , Gk | Y = 0) .
In general the multivariate distribution of G1, . . . , Gk for cases and controls is un-
known but can be estimated nonparametrically with the empirical frequency. How-
ever, in order to reduce overfitting, we propose the following estimation:
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Pˆ (G1 = g1, . . . , Gk = gk|Y = 1) =
∑n
i=1 1 {Gi1 = g1, . . . , Gik = gk, Y i = 1}∑n
i=1 1 {Y i = 1}
+ δ
and
Pˆ (G1 = g1, . . . , Gk = gk|Y = 0) =
∑n
i=1 1 {Gi1 = g1, . . . , Gik = gk, Y i = 0}∑n
i=1 1 {Y i = 0}
+ δ
where δ is a small value taken by default equal to 0.001. We discuss below the
overfitting problem.
The process stops after the prespecified number m of SNPs have been selected.
We can represent the forward selection process with a plot, that we refer as the
”forward selection curve”, that represents the optimal AUC at each step versus the
number of selected SNPs. Each curve has m dots with coordinates (k, AUCkopt),
k = 1, . . . ,m where AUCkopt denotes the optimal AUC of the first k selected SNPs
(G(1), . . . , G(k)).
To illustrate the forward selection process described above we consider again the
example introduced in the previous section: a simulated case-control dataset with
800 cases and 800 controls and 1000 SNPs where the first two SNPs (SNP1 and
SNP2) are associated with the outcome through an epistasis effect but without
marginal main effects. The challenge is how to detect this second order interaction
among all possible second or higher order interactions of the 1000 SNPs.
In Figure 5.3 we provide two plots. Both plots represent the selection process taking
SNP1 as the first SNP. The plot on the left is obtained without overfitting correction
(δ = 0) while for the plot on the right we used the default overfitting correction
(δ = 0.001). The different dots of the selection curves provide the Optimal AUC
in each step of the selection algorithm. In the first step, both plots provide an
optimal AUC around 0.5 which reflects the null discrimination accuracy of SNP1
individually. In the second step of the selection process the algorithm considers all
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the SNPs in combination of SNP1 and selects the one giving the largest prediction
accuracy. In this case, the selected SNP was SNP2 which, in combination with SNP1,
provides an optimal AUC of 0.86. The difference of correcting for overfitting or not is
manifest after this second step. In the plot on the left, where no overfitting correction
was applied, the Optimal AUC increases when a new SNP is added to the pair
(SNP1, SNP2). This increase is only apparent since only SNP1 in combination with
SNP2 are associated with the phenotype. When overfitting correction is applied, the
Optimal AUC decreases when new SNPs are added and the two interacting SNPs
can be identified. This example illustrates the need of correcting for overfitting in
the selection process.
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Figure 5.3: a) Forward selection curve with δ = 0 (no overfitting correction) b)
Forward selection curve with δ = 0.001 (with overfitting correction).
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5.3.2 Best model and inference
The selection process described before provides a total of p models (sets of m SNPs),
one for each initial SNP. The selection of the best model will be based on the forward
selection curves. In Figure 5.4 we see two forward selection curves corresponding
to 2 different models. The upper curve (dots are circles) represents the selection
process starting with SNP1 and the other curve (dots are triangles) represents the
selection process for SNP474. It is clear that the preferable model is the one that
achieves larger values. We consider the area under the forward selection curve
as the numerical summary that indicates wether a model achieves large values of
optimal AUC or not. The area under the forward selection curve is obtained as
Wj =
∑m
i=2
1
2
(AUCiopt + AUC
i−1
opt ) for j = 1, . . . , p.
We define the best model as the one with the largest areaWmax = max{W1, . . . ,Wp}.
This criterion is inspired in the optimal AUC interpretation. The curves with largest
areas will be the curves that reach larger values, in this case AUCopt values, and
grow fastest.
For the study of the statistical significance of results we need to obtain the empirical
distribution of Wmax under the null hypothesis of no association. In the absence of an
analytical expression we could obtain the null distribution through a permutational
approach but this would be computational unfeasible for large datasets. Instead,
since Wmax is the largest of a set of p areas Wi we can use the extreme value
distribution. We assume that the areas, Wi, are independent and normal distributed
under the null, Wi ∼ N (µ, σ) , i = 1, . . . , p. In this setting the extreme value
distribution is given by:
P (Wmax ≤ w) =
p∏
i=1
P (Wi ≤ w) =
[
Φ
(
w − µ
σ
)]p
where Φ indicates the standard normal distribution. Then, for a significance level
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Figure 5.4: Forward selection curves for the selection process starting with SNP1
(circles) and for the selection process starting with SNP474 (triangles).
α, the critical value wα is obtained by solving P (Wmax ≤ w) = 1− α and gives
wα = µ+ σΦ
−1[(1− α)1/p] .
Thus, the best model is significant at a level α when Wmax > wα.
Parameters µ and α are estimated empirically through a permutational approach.
In the example with two interaction SNPs, the best model is the one starting with
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SNP1 or the one starting with SNP2. Both models achieve the maximum area under
the forward selection curve among all the models, equal to Wmax = 0.7731. The
critical value in this example is wα = 0.6635 for α = 0.05. Thus, the best model is
significant.
5.3.3 Pruning
When the best model is significant, a further step is performed in order to refine the
selected subset of SNPs. This is similar to the pruning process in classification and
regression trees. The goal of this pruning process is to remove those SNPs that do not
increment significantly the W area. To do this we implement a backward elimination
process, we evaluate the SNPs in the reverse order that they were selected and we
remove them if their corresponding area increase is not significant. The pruning
process stops when a first significant SNP is found.
We start testing wether the last SNP, G(m) is significant or not. G(m) was selected as
the SNP providing the maximum increment in the optimal AUC, thus, we test the
significance of this increment by using the extreme value distribution. We assume
that the increments follow a normal distribution and its parameters µ and σ are
obtained through a permutational approach. In the example of Figure 5.4, the
optimal set after pruning is reduced to the pair of interacting SNPs: SNP1, SNP2.
5.3.4 Missing data
An important issue when dealing with multivariate genetic models is how to handle
missing genotypes. At each step of the forward stepwise process, a new SNP is
added to the selected set and a new partition of the dataset is made. After that,
the LR for each strata of the partition are computed. The problem arises with the
classification of the subjects that present a missing value for the added SNP. In this
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situation, we calculate the probability of the subject to belong to the new strata
based on their previous strata and the genotypes frequencies of the new SNP in that
strata. Finally we add the subject in all strata with a weight equal to the probability
of belonging to stratum. The new formulas for LR estimations considering missing
data are
Pˆ (g1, . . . , gk|Y = 1) =
∑n
i=1 1 {Y i = 1}
∏k
j=1w(G
i
j = gj)∑n
i=1 1 {Y i = 1}
+ δ
Pˆ (g1, . . . , gk|Y = 0) =
∑n
i=1 1 {Y i = 0}
∏k
j=1w(G
i
j = gj)∑n
i=1 1 {Y i = 0}
+ δ
where
w(Gij = gj) =

1 if Gij = gj
0 if Gij 6= gj
Pˆ
(
Gij = gj
)
if Gij is missing
and Pˆ
(
Gij = gj
)
is the genotype frequency of gj for the observed individuals.
For instance, given a partition with three SNPs, an individual who has the genetic
profile (0,NA, 1), that is, with a missing value in the second SNP, will contribute
to the genetic profile (0, 0, 1) with a weight of w(Gi2 = 0) equal to the frequency of
genotype ”0” for SNP2, to the (0, 1, 1) profile with a weight of w(Gi2 = 1) equal to
the frequency of genotype ”1” for SNP2 and to the genetic profile (0, 2, 1) with a
weight of w(Gi2 = 2) equal to the frequency of genotype ”2” for SNP2.
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5.4 Results
5.4.1 Simulation results
We conducted a simulation study to determine the power of the optimal AUC al-
gorithm to identify the SNPs involved in high-order interactions. We compared the
results with a marginal approach, the univariate logistic regression model.
We simulated case-control datasets consisting of a binary response variable (disease
status) and 100 SNPs using the R functions described in chapter 2. First, using
function SNPgenerate we obtained the genotypes for 100 independent SNPs. Sec-
ond, using function SNPinteact we generated the response variable assuming a
multiplicative odds of risk model (Section 2.3.2) and a K-th order interaction or
epistatic effect of the K first SNPs for K ∈ {2, 3, 4, 5}. As described in Subsection
2.4.2, this is achieved by randomly assigning the multi-locus genotypes (G1, . . . , GK)
of the causal interacting SNPs to a latent variable L ∈ {0, 1, 2}. We specify the rel-
ative risk of the three categories in L as RR = P (Y = 1|L = 1)/P (Y = 1|L = 0)
and RR2 = P (Y = 1|L = 2)/P (Y = 1|L = 0). We considered two values for the
relative risk, RR = 2 (high risk) and RR = 1.5 (low risk) and two different values
of disease prevalence, 0.1 and 0.02. In total we simulated 16 different scenarios re-
sulting from all combinations of these parameters. We maintained fixed the minor
allele frequency of every SNP at 0.2 and we generated 100 different datasets of size
4000 (2000 cases and 2000 controls) for each scenario.
For each simulated data set we applied the complete Optimal AUC process to build
the optimal subset of SNPs and analyzed their significance. In these simulations
we did not perform the pruning process, instead, we considered subsets of a fixed
number of SNPs equal to K, the number of causal SNPs.
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As mentioned before, we also applied a marginal approach, the univariate logistic
regression model where each SNP is tested separately for association with the dis-
ease. For each SNP we considered four possible models of inheritance (dominant,
recessive, additive and codominant) and take the minimum p-value of the four mod-
els. We set a SNP to be associated with the response when the p-value was smaller
than the significance level (α = 0.05) after adjusting for multiple testing using the
Benjamini and Hochger FDR correction (Benjamini and Hochberg, 1995).
As a measure of performance of both approaches for detecting an interaction of
K-th order we provide NJ , the number of simulated samples (over 100) for which
the methods were able to detect at least J causal SNPs, J ∈ {1, 2, 3, . . . , K}. The
best performance is achieved when NK = 100, meaning that the method was able
to detect all K causal interacting SNPs in all simulated samples. The results are
summarized in tables 5.2 to 5.5, each one corresponding to a different value of K.
Each row corresponds to the different combinations of risk and prevalence param-
eters and each cell provides the value NJ for the Optimal AUC algorithm and for
the marginal logistic regression in parenthesis.
The results prove a clear advantage of the Optimal AUC over the marginal logistic
regression in all the simulated scenarios. For instance, in the first row of Table 5.2,
that summarizes second order interactions, we observe that the Optimal AUC was
able to detect both interacting SNPs 81% of the times while the marginal approach
only detected both SNPs 67% of the times. The advantage of the Optimal AUC
over the univariate approach is more evident as the number K of causal interacting
SNPs increases. In the first row of Table 5.3 (third order interactions), the Optimal
AUC detected the three causal SNPs 87% of the times while the marginal approach
only 27% of the times. For interactions of order 4 and 5 the advantage is even more
extreme. In the first row of Table 5.4, the Optimal AUC detected the 4 interacting
SNPs 88% of the times while the marginal approach only 3% of the times and in
the first row of Table 5.5, the Optimal AUC detected the 5 causal SNPs 96% of
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the times while the marginal approach was never able to detect the five SNPs. We
obtained similar results for a prevalence of 0.10 and a prevalence of 0.02, thus, we
can conclude that the prevalence has not an important impact on the performance
of both approaches. Instead, their performance is affected by the risk level. When
the risk is low, we observe an important reduction of the number of causal SNPs
detected. But, even in this case, the Optimal AUC performs much better than the
univariate logistic regression.
Table 5.2: Performance of Optimal AUC algorithm and univariate logistic
regression (in parenthesis) for detecting two interacting causal SNPs.
Scenario Number of detected causal SNPs
Prevalence Risk 1 2
0.1 High 100 (97) 81 (67)
0.02 High 100 (95) 79 (56)
0.1 Low 97 (77) 59 (24)
0.02 Low 89 (81) 42 (14)
Table 5.3: Performance of Optimal AUC algorithm and univariate logistic
regression (in parenthesis) for detecting three interacting causal SNPs.
Scenario Number of detected causal SNPs
Prevalence Risk 1 2 3
0.1 High 100 (97) 98 (72) 87 (27)
0.02 High 100 (98) 99 (73) 87 (31)
0.1 Low 95 (74) 70 (17) 40 (1)
0.02 Low 93 (61) 69 (14) 37 (1)
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Table 5.4: Performance of Optimal AUC algorithm and univariate logistic
regression (in parenthesis) for detecting four interacting causal SNPs.
Scenario Number of detected causal SNPs
Prevalence Risk 1 2 3 4
0.1 High 100 (94) 100 (69) 99 (29) 88 (3)
0.02 High 100 (88) 100 (58) 98 (18) 89 (3)
0.1 Low 85 (54) 64 (16) 39 (1) 9 (0)
0.02 Low 75 (35) 58 (4) 26 (0) 8 (0)
Table 5.5: Performance of Optimal AUC algorithm and univariate logistic
regression (in parenthesis) for detecting five interacting causal SNPs.
Scenario Number of detected causal SNPs
Prevalence Risk 1 2 3 4 5
0.1 High 100 (77) 100 (44) 99 (14) 99 (0) 96 (0)
0.02 High 100 (79) 99 (37) 94 (16) 86 (3) 78 (0)
0.1 Low 69 (27) 51 (6) 29 (0) 16 (0) 3 (0)
0.02 Low 64 (30) 36 (3) 18 (0) 7 (0) 2 (0)
5.4.2 Alzheimer results
In this section we present the results for the Alzheimer disease association study in-
troduced in chapter 1.2. As described there, the data corresponds to a genome-wide
association study conducted by Reiman et al. (2007) with 502, 627 SNPs genotyped
for 1411 subjects of whom 861 were cases and 550 controls. An indicator variable is
also available that reports whether the individual is carrying the apolipoprotein E
(ApoE) 4 allelic variant, which is the best established genetic risk factor for late-
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onset Alzheimer’s disease (Reiman et al., 2007). Here we focus our analysis on the
Reelin signaling pathway with the goal of identifying genetic risk profiles or inter-
actions in genes within this pathway and to analyze potential interactions between
ApoE genotypes and those SNPs. For this, we identified 32 genes related to the
Reelin pathway and extracted 682 SNPs from Reiman’s database within these genes
(Table 1.4).
We applied the Optimal AUC algorithm for each gene separately. We conducted
a global analysis with all the patients, and a stratified analysis by the ApoE-4
indicator. We set the number of SNPs explored in each Optimal AUC process to be
m = 10. Afterwards, pruning was performed for those significant results. Table 5.6
shows the results for the stratified analysis. No significant subsets of SNPs were
detected in the global analysis.
For non carriers of ApoE-4 we obtained three significant interactions. The first re-
sult corresponds to a second order interaction between SNPs rs2855563 and rs6426554
in PSEN2 gene. This gene is located on the long arm of chromosome 1 and provides
instructions for making a protein called presenilin 2 that plays a role in processing
amyloid precursor protein. Patients with an inherited form of AD carry mutations
in the presenilin proteins or the amyloid precursor protein. The second significant
finding is also a second order interaction between SNPs rs11030102 and rs11030104
in BDNF gene, located on the short arm of chromosome 11. The protein encoded
by BDNF promotes the survival of neurons by playing a role in their growth, differ-
entiation and maintenance. The BDNF protein helps to regulate synaptic plasticity,
which is the ability of connections between neurons (synapses) to change and adapt
over time in response to experience. The last significant result is the interaction be-
tween SNPs rs2636277 and rs41346745 in ABL2 gene which encodes a non-receptor
tyrosine-protein kinase. In brain, it may regulate neurotransmission by phosphory-
lating proteins at the synapse. ABL2 acts also as a regulator of multiple pathological
signaling cascades during infection.
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Table 5.6: Significant sets of SNPs obtained by Optimal AUC algorithm
from Alzheimer’s disease data set.
ApoE-4 Gene SNPs
non carriers PSEN2 rs2855563 rs6426554
BDNF rs11030102 rs11030104
ABL2 rs2636277 rs41346745
carriers RELN rs1705107 rs4727582
rs2245617 rs3905915
rs17310949 rs4727583
For the stratum of ApoE-4 carriers, a significant subset of 6 SNPs was detected
in the RELN gene (rs1705107, rs4727582, rs2245617, rs3905915, rs17310949 and
rs4727583). The RELN gene is located on the long arm of chromosome 7 and
encodes a protein called reelin that plays a role in layering of neurons in the cerebral
cortex and cerebellum. Reelin likely plays a role in many brain processes, including
the extension of axons and dendrites, which are specialized outgrowths from nerve
cells that are essential for the transmission of nerve impulses. Reelin may also
regulate synaptic plasticity.
The Optimal AUC algorithm identified possible sets of SNPs that are jointly asso-
ciated with Alzheimer’s disease in interaction with ApoE-4. These results should
be confirmed in independent studies.
The information about gene functions in this section was compiled from the Genetics
Home Reference (GHR, 2015), the National Center for Biotechnology Information
(NCBI, 2015) and the UniProt Protein knowledgebase (The UniProt Consortium,
2015).
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SNPgenerate function
Simulation of genotype data on the assumption of independent SNPs.
SNPgenerate <- function(n,maf){
x <- NULL
for(i in 1:length(maf)){
p <- maf[i]
genfreq <- c((1-p)ˆ2,2*p*(1-p),pˆ2)
x[[paste("SNP",i,"_",maf[i],sep="")]] <-
sample(factor(c(0,1,2)), n, replace = TRUE, prob = genfreq)
}
return(as.data.frame(x))
}
LDgenerate function
Simulation of genotype data on the assumption of SNPs in LD.
LDgenerate <- function(x,r,maf=NULL,mafx=NULL){
if(missing(mafx)){
freq <- table(x)
if(length(freq)!=3)
stop("Error in GeneraSNPinLD: x must be 3 levels")
mafx <- 1 - (freq["1"]+2*freq["0"])/(2*sum(freq))
}
if(missing(maf)) maf <- rep(mafx,length(r))
if(length(maf)!=length(r))
stop("r and maf arguments have different lengths")
z <- NULL
for(i in 1:length(r)){
maf2 <- maf[i]
d <- r[i]*sqrt(mafx*(1-mafx)*maf2*(1-maf2))
if(d>0) d <- min( d, min((1-mafx)*maf2,mafx*(1-maf2)) )
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if(d<0) d <- max( d, -mafx*maf2 )
fAA <- (1-mafx)ˆ2
fAa <- 2*(1-mafx)*mafx
faa <- mafxˆ2
fAB <- (1-mafx)*(1-maf2) + d
fAb <- (1-mafx)*maf2 - d
faB <- mafx*(1-maf2) - d
fab <- mafx*maf2 + d
p0.0 <- fABˆ2 / fAA
p1.0 <- 2*fAB*fAb / fAA
p2.0 <- fAbˆ2 / fAA
p0.1 <- 2*fAB*faB / fAa
p1.1 <- (2*fAB*fab + 2*fAb*faB) / fAa
p2.1 <- 2*fAb*fab / fAa
p0.2 <- faBˆ2 / faa
p1.2 <- 2*faB*fab / faa
p2.2 <- fabˆ2 / faa
condProb <- rbind("0"=c(p0.0,p1.0,p2.0), "1"=c(p0.1,p1.1,p2.1),
"2"=c(p0.2,p1.2,p2.2))
colnames(condProb) <- c("0","1","2")
y <- rep(NA,length(x))
ind0 <- !is.na(x) & x==0
y[ind0] <-
sample(c(0,1,2), sum(ind0), replace=TRUE, prob=condProb["0",])
ind1 <- !is.na(x) & x==1
y[ind1] <-
sample(c(0,1,2), sum(ind1), replace=TRUE, prob=condProb["1",])
ind2 <- !is.na(x) & x==2
y[ind2] <-
sample(c(0,1,2), sum(ind2), replace=TRUE, prob=condProb["2",])
aux <- paste("LDx_",r[i],"_SNP",i,"_",maf2,sep="")
z[[aux]] <- factor(y, levels=c(0,1,2))
}
return(as.data.frame(z))
}
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RiskGenerate function
Simulation of disease outcome from multiple independent SNPs.
RiskGenerate <- function(data,RR,p){
LRsnp <- function(x,p,RR1,maf=NULL){
if(missing(maf)){
freq <- table(x)
maf <- 1 - (freq["1"]+2*freq["0"])/(2*sum(freq))
}
RR2 <- RR1ˆ2
g0 <- (1-maf)ˆ2
g1 <- 2*maf*(1-maf)
g2 <- mafˆ2
e <- p*g0/(g0 + RR2*g2 + RR1*g1)
a <- RR2*e*g2/g0
c <- RR1*e*g1/g0
b <- g2 - a
d <- g1 - c
f <- g0 - e
LR0 <- e*(1-p)/(f*p)
LR1 <- c*(1-p)/(d*p)
LR2 <- a*(1-p)/(b*p)
if(LR0<0 | LR1<0 | LR2<0)
stop("Incompatible combination of RR and p")
return(c(LR0=LR0,LR1=LR1,LR2=LR2))
}
if(length(RR)>1){
LRschema <- NULL
for(i in 1:ncol(data))
LRschema <- rbind(LRschema,LRsnp(data[,i],p=p,RR1=RR[i]))
}
else{
LRschema <- t(sapply(data,LRsnp,p=p,RR1=RR))
}
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LR <- NULL
for(i in 1:nrow(LRschema)) LR <- cbind(LR, LRschema[i,data[,i]])
rownames(LR) <- rownames(data)
log.odd <- apply(log(LR),1,sum) + log(p/(1-p))
odd <- exp(log.odd)
prob <- odd/(1+odd)
unif <- runif(length(prob))
y <- ifelse(prob>unif,1,0)
return(y)
}
SNPInteract function
Simulation of disease outcome under a genetic interaction disease model.
SNPInteract <- function(data,RR,p,hrp=NULL){
if(missing(hrp)){
mafData <- sapply(data, function(x){
freq <- table(x)
return(1 - (freq["1"]+2*freq["0"])/(2*sum(freq)))})
lmaf <- mean(mafData)
}
else{
lmaf <- sqrt(hrp)
}
n <- nrow(data)
maf <- lmaf
RR1 <- RR
RR2 <- RR1ˆ2
g0 <- (1-maf)ˆ2
g1 <- 2*maf*(1-maf)
g2 <- mafˆ2
e <- p*g0/(g0 + RR2*g2 + RR1*g1)
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a <- RR2*e*g2/g0
c <- RR1*e*g1/g0
b <- g2 - a
d <- g1 - c
f <- g0 - e
LR0 <- e*(1-p)/(f*p)
LR1 <- c*(1-p)/(d*p)
LR2 <- a*(1-p)/(b*p)
Partition <- function(p1,p2,index=NULL){
if(is.null(index)){
groups <- paste(p2,p1,sep=".")
}
else{
groups <- p2
groups[index] <- paste(p2[index],p1[index],sep=".")
}
x <- as.numeric(factor(groups))
return(x)
}
PartitionVar <- function(data){
if(class(data)=="data.frame"){
partition <- as.numeric(factor(data[,1]))
for(i in 2:ncol(data)) partition <- Partition(data[,i],partition)
}
else{
partition <- as.numeric(factor(data))
}
return(partition)
}
part <- PartitionVar(data)
aux <- factor(part)
aux <- factor(aux,levels=sample(levels(aux)))
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aux <- as.numeric(aux)
oscor <- order(aux)
AA <- round(n*(1-maf)ˆ2,0)
Aa <- round(n*2*(1-maf)*maf,0)
aa <- n-AA-Aa
X <- as.factor(c(rep(0,AA),rep(1,Aa),rep(2,aa)))
X <- X[order(oscor)]
LRschema <- c(LR0,LR1,LR2)
LR <- LRschema[X]
names(LR) <- rownames(data)
log.odd <- log(LR) + log(p/(1-p))
odd <- exp(log.odd)
prob <- odd/(1+odd)
unif <- runif(n)
y <- ifelse(prob>unif,1,0)
return(y)
}
Bin2Cont function
Simulation of continous outcome from binary outcome.
Bin2Cont <- function(y,mean0,sd0,mean1,sd1){
n <- length(y)
n0 <- sum(y==0)
n1 <- sum(y==1)
if(n!=n1+n0) stop("Error in y")
z <- rep(NA,n)
z[y==0] <- rnorm(n0,mean0,sd0)
z[y==1] <- rnorm(n1,mean1,sd1)
return(z)
}
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Bin2Surv function
Simulation of survival time outcome from binary outcome.
Bin2Surv <- function(y,tmax,shape0,scale0,shape1,scale1){
n <- length(y)
n0 <- sum(y==0)
n1 <- sum(y==1)
if(n!=n1+n0) stop("Error in y")
z <- rep(NA,n)
z[y==0] <- rweibull(n0,shape0,scale0)
z[y==1] <- rweibull(n1,shape1,scale1)
tuni <- runif(n,0,tmax)
ind <- z<=tuni
cens <- 1*ind
z[!ind] <- tuni[!ind]
return(data.frame(time=z,cens=cens))
}
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Package ‘AUCRF’
August 29, 2013
Type Package
Title Variable Selection with Random Forest and the Area Under the Curve
Version 1.1
Date 2012-03-19
Author Victor Urrea, M.Luz Calle
Maintainer Victor Urrea <victor.urrea@uvic.cat>
Depends R (>= 2.11.0), randomForest
Description Variable selection using Random Forest based on optimizing
the area-under-the ROC curve (AUC) of the Random Forest.
License GPL (>= 2)
LazyLoad yes
Repository CRAN
Date/Publication 2012-03-19 11:12:24
NeedsCompilation no
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2 AUCRF
AUCRF Variable Selection with Random Forest and the Area Under the Curve
Description
AUCRF is an algorithm for variable selection using Random Forest based on optimizing the area-
under-the ROC curve (AUC) of the Random Forest. The proposed strategy implements a backward
elimination process based on the initial ranking of the variables.
Usage
AUCRF(formula, data, k0 = 1, pdel = 0.2, ranking=c("MDG","MDA"), ...)
Arguments
formula an object of class formula: a symbolic description of the model to be fitted. The
details of model specification are given in Details.
data a data frame containing the variables in the model. Dependent variable must be
a binary variable defined as factor and codified as 1 for positives (e.g. cases)
and 0 for negatives (e.g. controls).
k0 number of remaining variables for stopping the backward elimination process.
By default k0=1.
pdel fraction of remaining variables to be removed in each step. By default pdel=0.2.
If pdel=0, only one variable is removed each time.
ranking specifies the importance measure provided by randomForest for ranking the
variables. There are two options MDG (by default) for MeanDecreaseGini and
MDA for MeanDecreaseAccuracy.
... optional parameters to be passed to the randomForest function. If no arguments
are specified, default arguments of randomForest function will be used.
Details
The AUC-RF algorithm is described in detail in Calle et. al.(2011). The following is a summary:
Ranking and AUC of the initial set:
Perform a random forest using all predictor variables and the response, as specified in the formula
argument, and compute the AUC of the random forest. Based on the selected measure of importance
(by default MDG), obtain a ranking of predictors.
Elimination process:
Based on the variables ranking, remove the less important variables (fraction of variables specified
in pdel argument). Perform a new random forest with the remaining variables and compute its
AUC. This step is iterated until the number of remaining variables is less or equal than k0.
Optimal set:
The optimal set of predictive variables is considered the one giving rise to the Random Forest with
the highest OOB-AUCopt. The number of selected predictors is denoted by Kopt
AUCRF 3
Value
An object of class AUCRF, which is a list with the following components:
call the original call to AUCRF.
data the data argument.
ranking the ranking of predictors based on the importance measure.
Xopt optimal set of predictors obtained.
OOB-AUCopt AUC obtained for the optimal set of predictors.
Kopt size of the optimal set of predictors obtained.
AUCcurve values of AUC obtained for each set of predictors evaluated in the elimination
process.
RFopt the randomForest adjusted with the optimal set.
References
Calle ML, Urrea V, Boulesteix A-L, Malats N (2011) "AUC-RF: A new strategy for genomic pro-
filing with Random Forest". Human Heredity. (In press)
See Also
OptimalSet, AUCRFcv, randomForest.
Examples
# load the included example dataset. This is a simulated case/control study
# data set with 4000 patients (2000 cases / 2000 controls) and 1000 SNPs,
# where the first 10 SNPs have a direct association with the outcome:
data(exampleData)
# call AUCRF process: (it may take some time)
# fit <- AUCRF(Y~., data=exampleData)
# The result of this example is included for illustration purpose:
data(fit)
summary(fit)
plot(fit)
# Additional randomForest parameters can be included, otherwise default
# parameters of randomForest function will be used:
# fit <- AUCRF(Y~., data=exampleData, ntree=1000, nodesize=20)
4 AUCRFcv
AUCRFcv Repeated cross validation of the AUC-RF process.
Description
Performes a repeated cross validation analysis and computes the probability of selection for each
variable.
Usage
AUCRFcv(x, nCV = 5, M = 20)
Arguments
x an object of class AUCRF.
nCV number of folds in cross validation. By default a 5-fold cross validation is per-
formed.
M number of cross validation repetitions.
Details
The results of this repeated cross validation analysis are (1) a corrected estimation of the predictive
accuracy of the selected variables and (2) an estimate of the probability of selection for each vari-
able.
The AUC-RF algorithm is exhaustively described in Calle et. al.(2011).
Value
The same AUCRF object passed (see AUCRF) as argument but updated with the following components:
cvAUC mean of AUC values in test datasets of the optimal sets of predictors.
Psel probability of selection of each variable as the proportion of times that is selected
by AUC-RF method.
References
Calle ML, Urrea V, Boulesteix A-L, Malats N (2011) "AUC-RF: A new strategy for genomic pro-
filing with Random Forest". Human Heredity. (In press)
See Also
OptimalSet, AUCRF, randomForest.
OptimalSet 5
Examples
# Next steps take some time
# load included AUCRF result example:
# data(fit)
# call AUCRFcv process:
# fitCV <- AUCRFcv(fit)
# The result of this example is included:
data(fitCV)
summary(fitCV)
plot(fitCV)
OptimalSet AUCRF optimal set selection.
Description
Returns the optimal set of predictive variables selected by the AUC-RF method.
Usage
OptimalSet(object)
Arguments
object an object of class AUCRF as the result of AUCRF or AUCRFcv functions.
Value
A data.frame with the selected variables ordered by the initial ranking, their importance values
(initial ranking) and, if available, the probability of selection value measured by AUCRFcv function.
See Also
AUCRF, AUCRFcv.
Examples
data(fitCV)
OptimalSet(fitCV)
6 plot.AUCRF
plot.AUCRF Plot Method for AUCRF
Description
The plot method for AUCRF objects.
Usage
## S3 method for class ’AUCRF’
plot(x, which=c("auc","ranking","psel"), showOpt=TRUE, digits=4,
maxvars=NULL, ...)
Arguments
x an object of class AUCRF as the result of AUCRF or AUCRFcv functions.
which specifies the information to plot. There are three options: (1) "auc" (by default)
to plot the curve of AUCs in the backwards elimination process, (2) "ranking"
to plot the importance measure in initial ranking of each variable, and (3) "psel"
to plot the probability of selection of each variable. The "psel" option is only
available if a cross validation is performed by AUCRFcv function.
For option (1), showOpt and digits arguments can be specified for more details
(see below).
For options (2) and (3), the number of variables to plot and their order preference
can be specified by maxvars and order arguments, respectively (see below).
showOpt (only applied if "auc" option is specified in wich argument). If showOpt=TRUE,
the optimal subset is emphasised in the plot.
digits (only applied if "auc" option is specified in wich argument and showOpt or
showThres are TRUE). Specifies the number of decimal digits for representing
the optimal AUC in the plot.
maxvars (only applied if "ranking" or "psel" options are specified in wich argument).
Number of variables to include in the plot. The specified number of variables
with highest importance measure (initial ranking) will be plotted. If maxvars=NULL
(by default) the selected variables will be plotted.
(For large number of variables, their names can be illegible in the plot)
... other graphical parameters (see par).
Examples
data(fitCV)
# Plotting the AUC in the AUCRF backward elimination process:
plot(fitCV)
# Plotting the probability of selection of the selected variables:
plot(fitCV, wich="psel")
plot.AUCRF 7
# Plotting the 20 variables with highest probability of selection:
plot(fitCV, wich="psel", maxvars=20)
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AUCRF font code
AUCRF function
Variable Selection with Random Forest and the Area Under the Curve.
AUCRF <-
function(formula,data,k0=1,pdel=0.2,ranking=c("MDG","MDA"),...){
AUC.randomForest <-
function(rf,clase=1){
r <- rank(rf$votes[,as.character(clase)])
rd <- mean(r[rf$y==clase])
nd <- sum(rf$y==clase)
nnd <- length(rf$y)-nd
return((rd-nd/2-0.5)/nnd)
}
MDGRanking <-
function(formula,data,...){
fitRF <- randomForest(formula,data=data,...)
mdgRanking <- sort(fitRF$importance[,"MeanDecreaseGini"],decreasing=
TRUE)
return(mdgRanking)
}
MDARanking <-
function(formula,data,...){
fitRF <- randomForest(formula,data=data,importance=TRUE,...)
mdaRanking <- sort(fitRF$importance[,"MeanDecreaseAccuracy"],
decreasing=TRUE)
return(mdaRanking)
}
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t <- 0
cl <- match.call()
mf <- match("formula", names(cl), 0L)
y <- eval(eval(cl[[mf]])[[2]],data)
if(!is.factor(y) && length(levels(y))!=2) stop("Outcome must be a
factor with two levels")
if(pdel<0 || pdel>=1) stop("pdel must be in the interval [0,1)")
ranking <- match.arg(ranking)
switch(ranking,
MDG = {ranking <- MDGRanking(formula,data,...); ImpMes <- "MDG
"},
MDA = {ranking <- MDARanking(formula,data,...); ImpMes <- "MDA
"},
stop("Not valid ranking")
)
mf <- match("formula", names(cl), 0L)
yname <- as.character(eval(cl[[mf]])[[2]])
vars <- names(ranking)
AUCcurve <- data.frame()
auxThres <- 0
auxMaxAUC <- 0
k <- length(vars)
while(k>=k0){
fitRF <- randomForest(formula,data=data[,c(yname,vars[1:k])
],...)
getAUC <- AUC.randomForest(fitRF)
if(getAUC>=auxMaxAUC){
auxMaxAUC <- getAUC
auxThres <- auxMaxAUC-t
}
if(getAUC>=auxThres) RFopt <- fitRF
AUCcurve <- rbind(c(k,getAUC),AUCcurve)
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k <- k-as.integer(pdel*k)-1
}
colnames(AUCcurve) <- c("k","AUC")
maxAUC <- max(AUCcurve$AUC)
opthreshold <- maxAUC-t
optimal <- AUCcurve[AUCcurve$AUC>=opthreshold,][1,]
objectList <- list()
objectList$call <- cl
objectList$data <- data
objectList$ranking <- ranking
objectList$Xopt <- names(ranking)[1:(optimal$k)]
objectList$"OOB-AUCopt" <- optimal$AUC
objectList$Kopt <- optimal$k
objectList$AUCcurve <- AUCcurve
objectList$RFopt <- RFopt
objectList$ImpMeasure <- ImpMes
class(objectList) <- "AUCRF"
return(objectList)
}
AUCRFcv function
Repeated cross validation of the AUC-RF process.
AUCRFcv <-
function(x,nCV=5,M=20){
AUC.votes <-
function(votes,y=NULL,clase=1){
if(missing(y) || is.null(y)) y <- votes$y
r <- rank(votes[,as.character(clase)])
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rd <- mean(r[y==clase])
nd <- sum(y==clase)
nnd <- length(y)-nd
return((rd-nd/2-0.5)/nnd)
}
cl <- match.call()
switch(class(x),
"AUCRF" = {
callRF <- x$call
data <- x$data
callRF$data <- as.name("newData")
yname <- as.character(eval(x$call$formula)[[2]])
},
stop("x must be a AUCRF object.")
)
cvAUC <- NULL
varnames <- colnames(data)[colnames(data)!=yname]
nSelect <- rep(0,length(varnames))
names(nSelect) <- varnames
for(m in 1:M){
CV <- list()
mpredict <- NULL
indPermuted <- matrix(c(sample(rownames(data)),rep(NA,nCV-nrow(data)
%%nCV)),ncol=nCV,byrow=TRUE)
for(k in 1:nCV){
indTest <- indPermuted[,k]
indTest <- indTest[!is.na(indTest)]
indTrain <- rownames(data)[!(rownames(data) %in% indTest)]
newData <- data[indTrain,]
kaucRF <- eval(callRF)
mpredict <- rbind(mpredict, predict(kaucRF$RFopt,newdata=data[
indTest,],type="vote"))
nSelect[kaucRF$Xopt] <- nSelect[kaucRF$Xopt]+1
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}
mvotes <- data.frame(y=data[,yname],mpredict[rownames(data),])
class(mvotes) <- c("votes","data.frame")
colnames(mvotes) <- c("y","0","1")
cvAUC <- c(cvAUC, AUC.votes(mvotes))
}
if(class(x)=="AUCRF")
objectList <- x
else
objectList <- list()
objectList$cvAUC <- mean(cvAUC)
objectList$Psel <- nSelect/(M*nCV)
objectList$callcv <- cl
class(objectList) <- c("AUCRFcv","AUCRF")
return(objectList)
}
OptimalSet function
AUCRF optimal set selection.
OptimalSet <-
function(object){
if(is.null(object$Psel))
out <- data.frame("Name"=object$Xopt,"Importance"=
object$ranking[object$Xopt])
else
out <- data.frame("Name"=object$Xopt,"Importance"=
object$ranking[object$Xopt], "Prob.Selection"=object$Psel[
object$Xopt])
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rownames(out) <- NULL
return(out)
}
summary.AUCRF function
Summary method for AUCRF.
summary.AUCRF <-
function(object,...){
return(object)
}
print.AUCRF function
Print method for AUCRF.
print.AUCRF <-
function(x,...){
cat("\nNumber of selected variables: Kopt=",x$Kopt,"\n")
cat("AUC of selected variables: OOB-AUCopt=",x$"OOB-AUCopt","\n")
if(!is.null(x$cvAUC)) cat("AUC from cross validation:",x$cvAUC,"\n")
cat("Importance Measure:",x$ImpMeasure,"\n")
cat("\n")
if(is.null(x$Psel))
res <- data.frame("Selected Variables"=x$Xopt, Importance=x$ranking
[x$Xopt])
else
res <- data.frame("Selected Variables"=x$Xopt, Importance=
x$ranking[x$Xopt], Prob.Select=x$Psel[x$Xopt])
rownames(res) <- NULL
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print(res)
}
plot.AUCRF function
Plot method for AUCRF.
plot.AUCRF <-
function(x, which=c("auc","ranking","psel") ,showOpt=TRUE, digits=4,
maxvars=NULL, ...){
cl <- match.call()
which <- match.arg(which)
opar <- par("cex", "pch")
on.exit(par(opar))
n <- ifelse(is.null(maxvars),x$Kopt, maxvars)
par(cex = max(1 - 0.1 * n %/% 10, 0.5), pch = 19)
switch(which,
psel={
if(is.null(x$Psel))
cat("No Psel information available. See AUCRFcv help.\n")
else{
imp <- x$Psel[x$Xopt]
imp <- sort(imp,decreasing=T)
if(!is.null(maxvars)) imp <- sort(x$Psel,decreasing=T)[1:
maxvars]
if(is.null(cl$pch)) dotchart(imp[length(imp):1],pch=par("pch")
,...)
else dotchart(imp[length(imp):1],...)
if(is.null(cl$xlab)) title(xlab="Probability of selection")
}
},
ranking={
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imp <- x$ranking[x$Xopt]
if(!is.null(maxvars)) imp <- sort(x$ranking,decreasing=T)[1:maxvars
]
if(is.null(cl$pch)) dotchart(imp[length(imp):1],pch=par("pch"),...)
else dotchart(imp[length(imp):1],...)
if(is.null(cl$xlab)) title(xlab=x$ImpMeasure)
},
auc={
par(opar)
type <- ifelse(is.null(cl$type), "o", eval(cl$type))
pch <- ifelse(is.null(cl$pch), 20, eval(cl$pch))
col <- ifelse(is.null(cl$col), 2, eval(cl$col))
if(is.null(cl$ylim)){
maxAUC <- max(x$AUCcurve$AUC)
minAUC <- min(x$AUCcurve$AUC)
r <- maxAUC-minAUC
ylim <- c(max(0,minAUC-r), min(1,maxAUC+r))
}
else{
ylim <- eval(cl$ylim)
}
ylab <- ifelse(is.null(cl$ylab), "OOB-AUC", eval(cl$ylab))
xlab <- ifelse(is.null(cl$xlab), "Number of selected variables",
eval(cl$xlab))
AUCcurve <- x$AUCcurve
m <- match(c("x","wich","showOpt","digits","maxvars","type", "pch",
"col", "ylim", "ylab", "xlab"), names(cl), 0L)
plotCall <- cl[-m]
plotCall[[1]] <- as.name("plot")
plotCall$x <- as.name("AUCcurve")
plotCall$type <- as.name("type")
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plotCall$pch <- as.name("pch")
plotCall$col <- as.name("col")
plotCall$ylim <- as.name("ylim")
plotCall$ylab <- as.name("ylab")
plotCall$xlab <- as.name("xlab")
eval(plotCall)
if(showOpt){
text(x$Kopt,x$"OOB-AUCopt"+(ylim[2]-ylim[1])/10, paste("OOB-
AUCopt = ",round(x$"OOB-AUCopt",digits)," (Kopt = ",x$Kopt,")
",sep=""), pos=4, cex=0.7, offset=0)
text(x$Kopt,x$"OOB-AUCopt","|", pos=3)
if(!is.null(x$cvAUC))
text(x$Kopt,x$"OOB-AUCopt"+1.5*(ylim[2]-ylim[1])/10, paste("
cvAUC = ",round(x$cvAUC,digits),sep=""), pos=4, cex=0.7,
offset=0)
}
}
)
invisible()
}
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APPENDIXC
Functions for the identification of high-order
interactions using the likelihood-ratio score
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trapz and auc.numeric functions
Computes the AUC measure for ROC curves and scores.
trapz <- function (x, y){
idx = 2:length(x)
return(as.double((x[idx] - x[idx - 1]) %*% (y[idx] + y[idx - 1]))/2)
}
auc.numeric<- function(x,y,clase=1){
r <- rank(x)
rd <- mean(r[y==clase])
nd <- sum(y==clase)
nnd <- length(y)-nd
return((rd-nd/2-0.5)/nnd)
}
ROCpart function
Computes optimal ROC for a partition.
ROCpart <- function(x, y, eps=1, type=c("auc","roc","lr","rs","all")){
type <- match.arg(type)
tab <- table(x,y)
marginTab <- prop.table(tab+eps,margin=2)
LR <- marginTab[,"1"]/marginTab[,"0"]
if(type=="lr") return(LR)
RS <- LR[as.character(x)]
ranko <- order(LR,decreasing=TRUE)
ROC <- apply(marginTab[ranko,],2,cumsum)
ROC <- rbind(c(0,0),ROC)
AUC <- trapz(ROC[,"0"],ROC[,"1"])
switch(type,
auc = out <- AUC,
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roc = out <- ROC,
rs = out <- RS,
all = out <- list(AUC=AUC,ROC=ROC,RS=RS,LR=LR)
)
return(out)
}
Partition and PartitionVar functions
Generates partitions from a variable sets.
Partition <- function(p1,p2,index=NULL){
if(is.null(index)){
groups <- paste(p2,p1,sep=".")
}
else{
groups <- p2
groups[index] <- paste(p2[index],p1[index],sep=".")
}
x <- as.numeric(factor(groups))
return(x)
}
PartitionVar <- function(data){
if(class(data)=="data.frame"){
partition <- as.numeric(factor(data[,1]))
for(i in 2:ncol(data)) partition <- Partition(data[,i],partition)
}
else{
partition <- as.numeric(factor(data))
}
return(partition)
}
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OASaucEval and OASaucTest functions
Computes the optimal AUC measure from a subset.
OASaucEval <- function(data,y,eps){
part <- PartitionVar(data)
LR <- ROCpart(part, y, eps, type="lr")
LR <- LR[as.character(part)]
auc <- auc.numeric(LR,y)
return(auc)
}
OASaucTest <- function(data,y,inbag,oob,eps){
part <- PartitionVar(data)
LR <- ROCpart(part[inbag], y[inbag], eps, type="lr")
LR <- LR[as.character(part[oob])]
LR[is.na(LR)] <- 1
auc <- auc.numeric(LR,y[oob])
return(auc)
}
OASnext, OAStep and OAStepRandom functions
Main Opimal AUC algorithm parts implementations.
OASnext <- function(data,y,part,eps){
allpart <- apply(data,2,Partition,p2=part)
aucs <- apply(allpart,2,ROCpart,y=y,type="auc",eps=eps)
best <- which.max(aucs)
aucmax <- aucs[best]
newvar <- colnames(data)[best]
newpart <- as.numeric(factor(allpart[,best]))
new <- list(part=newpart, auc=aucmax, addvar=newvar)
return(new)
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}
OAStep <- function(var1,data,y,eps,inbag=NULL,maxvars=15){
if(class(data)!="data.frame"){
data <- as.data.frame(data)
}
if(is.null(inbag)){
flag.test <- FALSE
inbag <- 1:nrow(data)
}
else{
flag.test <- TRUE
switch(class(inbag),
"character" = { indnames <- rownames(data)
oob <- indnames[!indnames %in% inbag] },
"integer" = { n <- nrow(data)
oob <- (1:n)[-inbag] },
stop("inbag argument not valid")
)
}
vars <- rep(0,ncol(data))
names(vars) <- colnames(data)
iter <- 1
vars[var1] <- 1
part <- Partition(data[inbag,var1],p2=1,index=NULL)
auc <- ROCpart(part,y[inbag],eps,type="auc")
testauc <- "n/d"
if(flag.test) testauc <- OASaucTest(data[,var1],y,inbag,oob,eps)
while(sum(vars>0)<maxvars){
iter <- iter + 1
newstep <- OASnext(data[inbag,vars==0],y[inbag],part=part,eps)
vars[newstep$addvar] <- iter
part <- newstep$part
auc[iter] <- newstep$auc
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if(flag.test) testauc[iter] <- OASaucTest(data[,vars!=0],y,inbag,
oob,eps)
}
return(list(auc=auc,testauc=testauc,vars=names(sort(vars[vars!=0]))))
}
OAStepRandom <- function(data,y,eps,inbag=NULL,maxvars=15){
if(class(data)!="data.frame"){
data <- as.data.frame(data)
}
if(is.null(inbag)){
flag.test <- FALSE
inbag <- 1:nrow(data)
}
else{
flag.test <- TRUE
switch(class(inbag),
"character" = { indnames <- rownames(data)
oob <- indnames[!indnames %in% inbag] },
"integer" = { n <- nrow(data)
oob <- (1:n)[-inbag] },
stop("inbag argument not valid")
)
}
vars <- rep(0,ncol(data))
names(vars) <- colnames(data)
rvar <- sample(names(vars),1)
part <- as.numeric(data[inbag,rvar])
iter <- 1
auc <- ROCpart(part, y[inbag], eps,"auc")
vars[rvar] <- iter
testauc <- "n/d"
if(flag.test) testauc <- OASaucTest(data[,vars!=0],y,inbag,oob,eps)
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while(sum(vars>0)<maxvars){
iter <- iter + 1
newstep <- OASnext(data[inbag,vars==0],y[inbag],part=part,eps)
vars[newstep$addvar] <- iter
part <- newstep$part
auc[iter] <- newstep$auc
if(flag.test) testauc[iter] <- OASaucTest(data[,vars!=0],y,inbag,
oob,eps)
}
return(list(auc=auc,testauc=testauc,vars=names(sort(vars[vars!=0]))))
}
FRutePurge function
Pruning the optimal subset.
FRutePurge <- function(rutaauc,kperms,Dades,y,inbag,eps,arperm=TRUE,
alpha=0.05,n){
nvars <- length(rutaauc)
rutasnps <- names(rutaauc)
deleting <- TRUE
historia <- NULL
while(deleting & nvars>1){
if(rutaauc[nvars]<rutaauc[nvars-1]){
historia <- cbind(historia,c(nvars,1,0,0))
nvars <- nvars-1
next
}
if(!arperm) return(rutaauc)
auxperm <- NULL
for(i in 1:kperms) auxperm <- cbind(auxperm,sample(Dades[inbag,
rutasnps[nvars]]))
allpart <- apply(auxperm,2,Partition,p2=PartitionVar(Dades[inbag,
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rutasnps[1:(nvars-1)]]))
aucs <- apply(allpart,2,ROCpart,y=y[inbag],type="auc",eps=eps)
permaucrutes <- sapply(aucs,function(a) c(rutaauc[1:(nvars-1)],a))
permars <- apply(permaucrutes,2,trapz,x=c(0:(nvars-1))/(nvars-1))
arthres <- mean(permars) + sd(permars) * qnorm((1-alpha)ˆ(1/n))
rutaar <- trapz(x=c(0:(nvars-1))/(nvars-1),y=rutaauc[1:nvars])
if(rutaar<=arthres){
historia <- cbind(historia,c(nvars,2,mean(permars),sd(permars)))
nvars <- nvars-1
next
}
historia <- cbind(historia,c(nvars,0,mean(permars),sd(permars)))
deleting <- FALSE
}
return(list(rutaauc[1:nvars], historia))
return(rutaauc[1:nvars])
}
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